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ABSTRACT OF DISSERTATION

CARDIAC RHYTHM DURING MECHANICAL VENTILATION
AND WEANING FROM VENTILATION
The transition from mechanical ventilation (MV) to spontaneous ventilation
during weaning is associated with hemodynamic alterations and autonomic nervous
system (ANS) alterations (reflected by heart rate variability [HRV]). Although cardiac
dysrhythmias are an important manifestation of hemodynamic alterations, development
of dysrhythmias during MV and weaning and subsequent impact on length of MV has
received little attention.
The purposes of this dissertation were to 1) evaluate the relationship of heart rate
variability (HRV) during weaning to the development of cardiac dysrhythmias and 2)
determine the relationship of cardiac dysrhythmias to length of MV.
A convenience sample of 35 patients (66.7% men; mean age 53.3 years) who
required MV was enrolled in this study. Continuous 3-lead electrocardiographic data
were collected for 24 hours at baseline during MV and for the first 2 hours during the
initial weaning trial. HRV was evaluated using spectral power analysis.
Twenty- seven patients out of 30 were exposed to a combination of pressure
support (8-15 cm H2O) and continuous positive airway pressure 5 cm H2O during
weaning trial. Three patients self- extubated and received supplemental oxygen through
either a partial rebreathing or non-rebreathing mask. Low frequency (LF) power HRV
decreased, while high frequency (HF) and very low frequency (VLF) power HRV did not
change during weaning. Multiple regression analyses showed that LF and HF HRV were
significant predictors of occurrence of ventricular and supraventricular ectopic beats
during weaning, while VLF power predicted occurrence of ventricular ectopic beats only.
The mean of occurrence of supraventricular ectopic beats per hour during weaning was
double the mean at baseline, while the mean of ventricular ectopic beats per hour did not
change. Mean number of supraventricular ectopic beats per hour during weaning was a
significant predictor of length of MV.
This dissertation has fulfilled an important gap in the evidence base for cardiac
dysrhythmias during weaning from MV. Cardiac dysrhythmias and HRV alterations

should be systemically evaluated during MV and weaning trials in order to decrease
length of MV.
KEYWORDS: Cardiac Dysrhythmias, Mechanical Ventilation, Weaning, Heart Rate
Variability, Length of Ventilation
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CHAPTER I:
CARDIAC RHYTHM DURING MECHANICAL VENTILATION AND WEANING
FROM VENTILATION
Significance of Problem
Mechanical ventilation (MV), a well established intensive care unit (ICU) strategy,
is used increasingly often to support pulmonary function in critically ill patients.
critical care units, as many as 90% of patients require MV.

1, 3-5

1, 2

In

Despite its lifesaving

potential, MV is associated with a wide variety of risks including ventilator-associated
pneumonia, barotrauma, cardiovascular compromise, and diaphragm fatigue.6,

7

Prolonged MV increases the possibility of occurrence of these complications.7
Reintubation following accidental or intentional premature extubation is also associated
with high morbidity, mortality, health care costs, longer ICU and hospital stay, and a
greater chance to transfer to a rehabilitation institution.

1, 8, 9

Thus, the goal for

mechanically ventilated patients is to transition back to spontaneous ventilation as rapidly
as feasible, a process called weaning.3 Liberation from MV may be easily achieved in
most patients who require routine postoperative ventilator support or those with overdose
of sedatives. However, weaning is often difficult and the chance of failure is higher in
patients who have chronic pulmonary disease, heart failure, central nervous system
dysfunction, renal failure, hepatic failure or sepsis. 8-10
During weaning, different modes of spontaneous ventilation can be used that
result in different hemodynamic responses that are dependent on intrathoracic pressure
(ITP) changes inherent to each12, 13 and the individual’s underlying cardiac function. 12, 14,
15

Unfortunately, about one third of mechanically ventilated patients exhibit significant

difficulty weaning from MV 9, 16, 17 and consequently have a longer duration of MV and a
longer hospital stay.

The Collective Task Force of the American College of Chest

Physicians, the American Association for Respiratory Care, and the American College of
Critical Care has identified weaning from MV as a research priority.18
Multiple investigators have examined the impact of oxygenation failure,
respiratory muscle dysfunction and cardiovascular dysfunction as major factors in
weaning outcomes.19-28 Although dysrhythmias are an important manifestation of
cardiovascular dysfunction, the development of dysrhythmias during weaning and
subsequent impact on length of MV has received little attention.

1

The transition from MV to spontaneous ventilation during the weaning process
can induce hemodynamic alterations

14, 29-32

as a result of changes in intrathoracic blood

volume. Altered autonomic nervous system (ANS) response (reflected by decreased heart
rate variability [HRV])

33, 34

to hemodynamic alterations can cause dysrhythmias.35-45

Dysrhythmias subsequently may increase the length of MV as suggested in the study
proposed model (Figure 1).
Model for Testing Hypotheses
Changes in intrathoracic pressure (ITP) and lung volume that occur during
weaning may induce significant hemodynamic changes that influence thoracic blood
volume and flow.12, 27, 33 The autonomic nervous system responds to the hemodynamic
alterations inherent to different weaning modes in order to maintain adequate cardiac
output and oxygen delivery. Compensatory ANS alterations include changes in heart rate,
ventricular afterload, contractility, and filling time. However, altered ANS tone (reflected
by decreased HRV) in response to hemodynamic alterations during weaning could be
arrhythmogenic

46

depending on the magnitude of hemodynamic alterations, underlying

cardiovascular function, and the adequacy of compensatory mechanisms.7, 14, 15 Patients
who develop cardiac dysrhythmias during weaning may have inadequate cardiac output
and oxygen delivery required for metabolic needs and consequently fail weaning attempts.
In this study, we hypothesized that there is a relationship between the occurrence
of dysrhythmias during initial weaning attempt and length of MV (Figure 1.1). Patients
with underlying cardiovascular dysfunction and impaired compensatory mechanisms for
hemodynamic changes in response to weaning attempts may experience significant
cardiac dysrhythmias.17 Patients with cardiac dysrhythmias may fail to wean from MV
and require longer support from MV.
Purpose of the Study
The purposes of this study were to 1) evaluate the relationship HRV (as a
noninvasive reflection of ANS tone) during weaning to the development of cardiac
dysrhythmias and 2) determine the relationship of cardiac dysrhythmias during weaning
to length of MV. Clinically significant cardiac dysrhythmias (i.e., ventricular ectopy,
ventricular

tachycardia/fibrillation,

atrial

fibrillation/flutter,

and

supraventricular

tachycardia) were the focus of this study because of their potential negative consequences

2

in patients who are undergoing weaning trials. Studying and identifying cardiac
dysrhythmias that occur during MV and weaning, and determining the role that
dysrhythmias might play in length of MV are vital in order to provide appropriate care
and management for mechanically ventilated patients.
Specific Aims
The specific aims of the study were the following:
1: To determine the relationship of HRV (measured in the frequency domain)
during weaning to the development of cardiac dysrhythmias after controlling for baseline
HRV measured during MV.
Hypothesis 1: HRV measured in the frequency domain during weaning will be
related to the occurrence of cardiac dysrhythmias. That is, in patients with cardiac
dysrhythmias during weaning compared to those without dysrhythmias, HRV will
demonstrate higher power in the low frequency (0.04 to 0.15 Hz range) and very
low frequency (< 0.04 Hz), and decreased power in the high frequency range
(0.15 to 0.40 Hz).
2: To determine the relationship of the occurrence of dysrhythmias during
weaning to length of MV after controlling for Acute Physiology and Chronic Health
Evaluation (APACHE) IV score.
Hypothesis 2: Rate of dysrhythmias per hour during weaning will be an
independent predictor of length of MV.

Figure1.1: Conceptual model of the relationship between heart rate variability,
dysrhythmias and length of ventilation
Weaning

↓ Heart rate
variability

Dysrhythmias
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Length of
Ventilation

CHAPTER II
REVIEW OF LITERATURE
Transition from MV to spontaneous ventilation during the weaning process
produces hemodynamic alterations and autonomic nervous system (ANS) dysfunction
(reflected by decreased HRV) especially in patients with underlying cardiovascular
dysfunction. Autonomic nervous system alterations can cause cardiac dysrhythmias
depending on underlying cardiovascular function and adequacy of compensatory
mechanisms. Although dysrhythmias that develop during weaning are often clinically
significant, there is paucity of research on expression of dysrhythmias during weaning
and its impact on length of MV.
Management of dysrhythmias that develop during weaning from MV is vital
because dysrhythmias can induce myocardial ischemia, impair myocardial contractility
and decrease cardiac index, eventually leading to weaning failure and longer time of MV.
Prolonged MV is associated with a variety of risks and complications such as ventilatorassociated pneumonia, lung barotrauma, and cardiovascular compromise.6, 7
The purpose of this chapter is to provide a physiological background of factors
that contribute to occurrence of cardiac dysrhythmias during weaning. The focus is on
physiology of cardiac action potential, underlying mechanisms of cardiac dysrhythmias,
and physiology of HRV. Cardiovascular effects of mechanical ventilation and weaning;
relationship between HRV to the development of cardiac dysrhythmias during weaning,
process of weaning from MV, measurement of HRV are reviewed and presented in this
chapter also.
Heart- lung interaction during mechanical ventilation and weaning from ventilation
Cardiac and pulmonary systems interact with each other during spontaneous and
mechanical ventilation. This interaction involves mechanical, neural, and humoral
mechanisms.14,

30, 47

Intrathoracic structures including the heart, pericardium, great

vessels and veins are affected by changes in the surrounding pressure, which are the
pleural pressure and ITP.14 Changes in pleural pressure, ITP, and lung volume associated
with spontaneous ventilation and MV affect the determinants of stroke volume—preload,
afterload and myocardial contractility. 14, 15, 32, 47-49

4

Cardiovascular effects of spontaneous ventilation.
During spontaneous inspiration, negative ITP induces a decrease in right atrial
pressure and an increase in RV transmural pressure (i.e., the difference between cardiac
intramural and extramural pressure). The decrease in right atrial pressure and the increase
in right ventricular (RV) transmural pressure subsequently increase the pressure gradient
between vana cava and right atrium for venous return to the heart. The result of increased
venous return to the right heart is an increase in intrathoracic vascular volume and RV
diastolic filling volume.50 The increase in intrathoracic vascular volume and RV diastolic
filling volume increases RV end- diastolic volume, which results in an increase in stroke
volume by the Frank-Starling mechanism. Changes in left ventricular (LV) preload tend
to follow RV preload within 1-2 beats.50
An increase in RV end- diastolic volume results in a decrease in LV diastolic
compliance and end-diastolic volume through ventricular interdependence and leftward
septal shift. LV afterload increases secondary to the increased LV transmural pressure.
As a result, LV stroke volume decreases and a fall (<10mmHg) in systolic blood pressure
during inspiration is observed.

51, 52

The decrease in systolic blood pressure stimulates

the baroreceptor reflex, which consequently increases sympathetic outflow to the heart
and a slight increase in heart rate occurs.
In summary, negative ITP that occurs during spontaneous inspiration causes
increased venous return, RV preload and LV afterload, leading to a small fall in systolic
blood pressure and a slight increase in heart rate.
Cardiovascular effects of mechanical ventilation.
Unlike spontaneous breathing, positive pressure MV results in an increase in ITP
during inspiration and throughout the respiratory cycle if positive end expiratory pressure
(PEEP) or continuous positive airway pressure (CPAP) are used. 49
During inspiration, positive ITP is associated with decreases in venous return and
RV transmural pressure, causing a reduction in RVEDV (preload).53, 54 Also, positive ITP
and expanding lung volume compress vena cava and RV, which in turn cause a reduction
in RV preload. At peak lung inflation, especially in severe obstructive pulmonary disease
with lung hyperinflation, or when PEEP is applied, pulmonary vascular resistance (PVR)
is elevated and RV ejection is impeded.

7, 55, 56

5

In critically ill patients (e.g., patients with

adult respiratory distress syndrome), increases in PVR may markedly increase RV
afterload, and induce acute cor pulmonale and cardiovascular collapse secondary to
excessive RV dilation, RV ischemia, and compromised LV filling.

56, 57

Right ventricular output directly influences left atrial and LV filling volume and
output. Decreased RV end- diastolic volume and RV ejection decrease pulmonary venous
flow, LV end- diastolic volume,58 LV stroke volume, and cardiac output. Positive ITP
reduces LV afterload by decreasing transmural LV systolic pressure.59 Reduction in LV
afterload facilitates ventricular ejection and helps maintain cardiac output (CO), although
sometimes at a lower level than normal, during MV.2
Given the tendency toward a lower CO in some patients receiving MV and to
increase blood pressure and maintain adequate cardiac output, the neurohormonal system
responds to these hemodynamic alterations by secreting catecholamines, vasopressin and
rennin. Activation of rennin- angiotensin system induces increases in angiotensin II and
aldosterone levels. The result of increases of these neurohormones includes tachycardia,
vasoconstriction, oliguria, and retention of sodium and water, and subsequently increases
in blood pressure. An increase in heart rate occurs as an initial response to lower CO.
This can be seen in the beat-to-beat variations in heart rate that compensate for cyclical
differences in RV and LV output.

Lung inflation mediates these instantaneous

cardiovascular alterations by modulating autonomic tone. The lungs are highly innervated
with autonomic fibers. Normally, lung inflation with tidal volume <10ml/kg induces
vagal tone withdrawal and increases heart rate, producing the phenomenon of respiratory
sinus arrhythmia. Lung inflation of >15ml/kg tidal volume induces both increased vagal
tone and sympathetic withdrawal, which produces heart rate decreases.7
In summary, positive ITP that is associated with positive pressure ventilation
causes decreases in venous return, RV end- diastolic volume, and LV afterload.
Decreases in preload and afterload cause a dramatic decrease in CO in patients with
hypovolemia.60 Decreases in preload and afterload may improve CO and decrease oxygen
demand in patients with hypervolemic heart failure, or impaired cardiac function.

6

Cardiovascular effects of weaning.
Conceptually, "ventilator weaning" represents the period of transition from total
ventilatory support to spontaneous breathing.

18, 61, 62

On average, weaning accounts for

40% of the total duration of mechanically ventilatory support.3,

63

During ventilator

weaning, different modes of spontaneous ventilation can be used that result in different
hemodynamic responses dependent on ITP changes inherent to each. 12, 13 Up to one third
of mechanically ventilated patients fail weaning trial.9, 16, 17 The hemodynamic responses
to

weaning

include

cardiovascular

dysfunction,

autonomic alteration,

cardiac

dysrhythmias, and myocardial ischemia.
During weaning, ITP decreases. The degree of ITP reduction depends on the
mode used. The decrease in ITP may result in abrupt increases in venous return, RV
preload and LV afterload. Also during weaning, hypoventilation and alveolar hypoxia
may occur.

Hypoventilation and alveolar hypoxia induce hypoxic pulmonary

vasoconstriction, profoundly increasing PVR, RV afterload64 and subsequently
decreasing RV ejection. Reduced RV ejection induces RV dilatation, decreases coronary
blood flow, and shifts the interventricular septum to the left. Increased LV afterload may
impede LV ejection and result in increases in LV end-diastolic volume and pressure. LV
dilation, further increase in LV afterload, pulmonary edema secondary to acute heart
failure, and coronary blood flow reduction may occur.

Alterations in preload and

afterload that occur during weaning may induce acute cardiac mechanical changes and
ANS alterations that may be arrhythmogenic.
Acute ventricular loading (preload) or dilation that occurs during weaning plays
an important role in the development of cardiac dysrhythmias. Mechanical changes (i.e.,
cardiac chambers loading and stretch) have been shown to induce significant
electrophysiological changes (i.e., shortening

myocardial action potential and

refractoriness) mediated by cardiac myocyte stretch-activated channels and selective-ion
channels.65,

66

This mechano-electrical feedback mechanism induces atrial and

ventricular dysrhythmias, predominantly ectopic beats, non-sustained ventricular
tachycardia, and atrial dysrhythmias.

The risk of dysrhythmia development during

7

weaning is higher in patients with impaired ventricular function and congestive heart
failure who have chronic regionally or globally impaired dilated hearts and are subject to
pressure /volume overload.65-73
Changes in ANS tone occur as a result of fluid shifts into the intrathoracic
vascular compartment from changes in ITP.12, 27, 33 The ANS compensates for these fluid
shifts by an increase in sympathetic tone and a decrease in parasympathetic tone. The
result is a decrease in HRV and further increase in LV afterload. Sympathetic dominance
is associated with negative effects on the cardiac myocyte action potential (i.e., decreased
ventricular refractoriness, increased myocardial excitability) that may enhance abnormal
automaticity, triggered activity and reentry mechanisms of cardiac dysrhythmias.
Cardiac dysrhythmias may impair myocardial oxygen delivery and cardiac pumping,
resulting in myocardial ischemia and low cardiac index.
Myocardial ischemia results from an imbalance between oxygen supply and
demand. During weaning, oxygen supply may be reduced by hypoxemia, inadequate
coronary blood flow, and dysrhythmias. Pulmonary edema that may occur during
weaning causes ventilation-perfusion mismatching as manifested by hypoxemia.
Inadequate coronary blood flow is produced by ventricular dilation, and increased LV
end-diastolic pressure and afterload. Cardiac dysrhythmias, particularly ectopic beats,
may limit diastolic filling time and oxygen supply and induce myocardial ischemia.
Significant cardiac dysrhythmias and myocardial ischemia may cause ventricular
hypokinesis or dyskinesis, which in turn decreases ejection fraction and results in low
cardiac index. Weaning failure and increased mechanical ventilation time may result.
Overall, patients with cardiovascular dysfunction and impaired compensatory
mechanisms for alterations in right and left preload and afterload; and ANS that occur
during weaning may experience significant cardiac dysrhythmias. Dysrhythmias can
induce myocardial ischemia,19, 22, 25, 28, 74-76 impair myocardial contractility,

76

decrease

ventricular ejection fraction and cardiac index, eventually leading to weaning failure and
longer length of ventilation.

8

Cardiac Rhythm
Normal cardiac rhythm.
Heart rhythm, the normal occurrence of heart beats in regular intervals, is initiated
by intrinsic electrical system composed of modified myocytes. These modified myocytes
include the SA node, atrioventricular (AV) node, the bundle of His and Purkinjie
fibers.77-79
The depolarization of the heart is normally initiated by the SA node “the
pacemaker of the heart”.79 The SA node is a cluster of specialized cells that generates the
initial electrical impulse of each normal heart beat. Electrical impulses from the SA node
stimulate adjacent cells and are transmitted through the atria to the AV node via
conducting internodal tracts. The AV node slows conduction velocity and thus delays
impulse transmission. Then, a specialized conduction pathway composed of Bundle of
His and Purkinjie fibers conduct the wave of depolarization throughout the ventricles to
initiate ventricular contraction.79
The SA node is considered the pacemaker of the heart because it has the greatest
rate of spontaneous firing. If the SA node fails to produce impulses, as seen in heart
blocks, the tissue with the next highest automaticity rate, typically the AV node functions
as the pacemaker. If the AV node fails to produce impulses, the Bundle of His may
function as the pacemaker. However, the rate of depolarization of the Bundle of His is
less than the rate of depolarization of the SA and AV nodes.77-80
The SA node is innervated by both sympathetic and parasympathetic nerve fibers.
At rest, parasympathetic fibers dominate and release acetylcholine that slows rate of
depolarization of the SA node and maintains heart rate between 60 and 80 beats/min.
During exercise, relative withdrawal of vagal tone and activation of sympathetic nerves
occur. The sympathetic nerve fibers release norepinephrine that increases the SA node
rate of depolarization resulting in increased in heart rate.78,

79, 81

In addition to the

sympathetic and parasympathetic nervous system, the intrinsic rate of SA depolarization
is modulated by baroreceptor activity, the intrinsic cardiac nervous system,
cardiopulmonary reflexes, and respiration.

9

The phenomenon in which respiration modulates the SA node depolarization rate
and cyclical variation stroke volume and consequently cardiac output is referred to as
respiratory sinus arrhythmia (RSA). The negative ITP and positive intra-abdominal
pressure that occur during spontaneous inspiration enhance RV filling and stroke volume.
At the same time, lung expansion that occurs during inspiration causes pooling of blood
in the pulmonary circulation and decreases the return of blood to the left ventricle.
Consequently, LV stroke volume decreases transiently, vagal efferent stimuli are
inhibited and heart rate increases. The reverse occurs during expiration,77 whereas
efferent vagal is stimulated and heart rate decreases.
Overall, withdrawal of vagal tone occurs during inspiration77 and results in the
physiologic phenomenon called respiratory sinus arrhythmia, an observable manifestation
of HRV that reflects the ability of the body to make beat-by-beat adjustments in cardiac
output.
Electrophysiology of cardiac excitation.
Cardiac tissue is excitable and capable of responding to stimulation with a large,
rapid shift in membrane voltage.77, 79, 80 Cyclical depolarization and repolarization of the
cell in which changes of the membrane voltage occur is called an action potential. The
action potential lasts only for a few hundred milliseconds and triggers a sequence of
organized myocardial contraction.77, 79, 80
Physiology of action potential.
The action potential consists of five phases: rapid upstroke (phase 0), early
repolarization (phase1), a plateau (phase 2), repolarization (phase 3), and resting potential
(phase 4). Phases of action potentials result from movement of sodium (Na+), Ca+2 and
potassium (K+) ions across the cell membrane through various ion channels and exchange
pumps.77, 79, 80
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Resting membrane potential.
The resting membrane potential (phase 4) is generated by differences in ion
concentration across the cell membrane. Potassium ions are highly concentrated inside
the cell; while Na+ is highly concentrated outside the cell membrane. At resting state, the
cell membrane is highly permeable to K+ ions through the inward rectifier channel (iK ir).
Sodium inward movement through the inward background current is very small
compared to K+ movement. However, the resting membrane potential remains stable
despite the continuous slow exchange of K+ for Na+.77, 79, 80
Types of cardiac action potentials.
There are two main types of cardiac action potentials: fast and slow response
action potentials. The speed of conduction through tissue is a function of the slope and
amplitude of phase 0. Fast-response action potential occur in the atrial and ventricular
myocytes and purkinjie fibers. These cells depolarize rapidly, conduct stimulation rapidly
to the adjacent cell, and have a sustained plateau phase.77-80 Slow response action
potential occur in pacemaker cells, the SA and AV nodes of the heart. These cells
depolarize spontaneously, slowly and have a shorter plateau phase. 77, 79, 80
Fast- response action potentials.
The working myocardial cells of the atria and ventricles and Purkinje fibers are
examples of fast response action potentials.

77-80

Fast-response cells have a resting

membrane potential of approximately -90mv. Excitation of these cells by an action
potential from an adjacent cell causes a rapid depolarization to a threshold voltage of
about -60 to -65 mV. Once this threshold voltage is reached, the Na+ channels open and
a large inward directed, depolarizing Na+ currents (INa) enter the cell and the initial
overshoot upstroke (Phase 0) occurs with a peak voltage of +20 to +30 mV.

The

overshoot is brief because the Na+ channels automatically inactivate after a few
milliseconds.
At early repolarization (phase 1), the Na+ channels are spontaneously and rapidly
inactivated, but a special type of transient outward K+ channel (ito) opens, causing a
small, early, rapid but incomplete repolarization of the cell to approximately +10 mV. At
Phase 2 (plateau), the increase in inward Ca+2 current (iCa) down the electrochemical
gradient through L-type calcium channels is nearly counterbalanced by the repolarizing
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effect of the outward K+ current (IK1), resulting in a plateau period in the region of 0mV,
which lasts 200-400 msec. During this phase, the increase in Ca+2 entry has a positive
inotropic effect on the myocardial cells during contraction. The increase in cytosolic Ca+2
concentration that occurs during plateau activates the Na+-Ca+2exchanger. The Na+-Ca+2
exchanger allows three extracellular Na+ to enter the cell in exchange for one Ca+2
expelled outside the cell.

The plateau inward Na+ current created by the Na+-Ca+2

exchanger maintains the late plateau. Eventually, at phase 3, the delayed rectifier K+
currents dominate and Ca+2 channels becomes inactive, causing rapid repolarization of
the cell back to the -90 mV resting membrane potential.
Physiological and pathological changes in action potential plateau.
Duration of the action potential plateau is determined mainly by the size of K+
currents.77-80 In circumstances of tachycardia induced by sympathetic nerve stimulation,
action potential shortens due to the increased size of repolarizing K+ currents.
During hypoxia, ATP concentration falls while ADP and H+ concentrations rise,
which in turn increases the opening of KATP channels. The resulting increase in K+
currents not only induces early repolarization and shortens the action potential but also
decreases Ca+2 entry during action potential. Decreased Ca+2 entry has negative inotropic
effect. High sympathetic nerve activity in ischemic hearts triggers cardiac dysrhythmias.
In chronic heart disease and heart failure, the action potential lengthens. The
genetic abnormality of the delayed rectifier K+ channels (long Q-T syndrome) that occur
in chronic heart disease prolongs the action potential plateau and leads to Ca+2 overload
and afterdepolarization, which may in turn triggers arrhythmia.77-80
Antiarrhythmic drugs can alter the action potential of fast-response cells. βadrenergic agonists increase the duration and amplitude of the plateau by increasing Ca+2
currents. Sodium-channel blockers inactivate fast Na+ channels and decrease the slope of
phase 0. Potassium-channel blockers delay repolarization (phase 3) by blocking the K+
channels.77-80
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Slow response action potential.
The slow response action potential is most often found in the SA and AV nodes.
These cells have the ability to depolarize spontaneously, a property called
automaticity.Unlike non-pacemaker action potentials, the action potential in nodal tissue
has only 3 phases. Phase 0 is determined primarily by the currents through T- and L-type
slow inward calcium channels.
The SA node does not involve fast Na+ currents. The SA and AV nodal tissues
depolarize spontaneously during phase 4 via the funny channels (If). During phase 4 and
when membrane potential is about -60 mV, the funny channels (If) open and conduct
slow, inward Na+ currents causing the membrane potential to depolarize spontaneously.
When the membrane potential reaches about -50 mV, the T- and L-type calcium channels
open, consequently causing Ca+2 influx and the membrane continues to depolarize until
an action potential threshold is reached (usually between -40 and -30 mV).
Repolarization (Phase 3) occurs as K+ channels (Ik) open and the L-type calcium channels
become inactivated and close.77-80
Although nodal tissue depolarizes spontaneously, its rate of firing is altered by
many factors such as the ANS. The SA node is highly innervated by sympathetic and
parasympathetic fibers. Parasympathetic (vagal) activation dominates over sympathetic
influences at rest, while sympathetic activation dominates during stress and exercise.
Acetylcholine released by vagal nerve decreases the SA activation rate by increasing K+
and decreasing slow inward calcium and Na+ currents. Norepinephrine released by
sympathetic fibers increases pacemaker rate by decreasing K+ and increasing slow
inward calcium and Na+ currents.77-80
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Absolute and relative refractory periods.
Refractoriness refers to the inability of cardiac tissue to be re-excited. During
depolarization, the cell goes through a period in which it becomes refractory to
subsequent depolarizing events. This period is generally divided into 2 phases: the
absolute refractory period and the relative refractory period. The absolute refractory
period involves phases 0, 1, 2, and part of phase 3. During absolute refractory period, no
new action potential can be initiated, regardless of the magnitude of the stimulus. The
absolute refractory period serves as a protective mechanism against reentry
dysrhythmias.77, 79
During the relative refractory period, the Na+ and Ca+2 channels are closed but are
capable of activation. Thus, only a stimulus that exceeds the normal threshold can initiate
a subsequent depolarization. 77, 79
Overall, action potential initiates organized sequence of contractions in the heart.
The phases of action potential vary from region to region in the heart. The longest
duration of these action potentials is found in the cells of Purkinjie fibers, which works as
a safeguard against re-entrant dysrhythmias.
Cardiac dysrhythmias
Cardiac dysrhythmias, any abnormality in normal cardiac rhythmic pattern, are
common and important clinical problems in patients receiving MV or undergoing the
process of weaning from MV.17 Cardiac dysrhythmias result primarily from either
abnormalities of impulse formation, impulse conduction, or both.77,

79

Abnormal

automaticity, triggered activity and reentry mechanisms are responsible for the most
clinically important and potentially malignant dysrhythmias such as ventricular ectopic
beats, ventricular tachycardia/fibrillation, atrial fibrillation/flutter, and supraventricular
tachycardia.

82, 83

In addition, abnormalities of mechanical loading (i.e., increased

intrathoracic vascular volume) can induce dysrhythmias through a mechano-electrical
feedback mechanism.46, 65, 67, 68, 70, 72, 73, 84
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Abnormal automaticity.
Automaticity refers to the ability of cardiac cells to depolarize spontaneously and
initiate an electrical impulse without the effect of external stimuli.

77-79, 81

Abnormal

automaticity is an abnormal condition generated by sustained ventricular excitability and
repetitive afterdepolarization.77-79, 81 Conditions such as ischemia, hypoxia, acidosis, and
hyperkalemia can induce abnormal automaticity.77-79, 81
Ischemia and hypoxia mainly interfere with the function of the Na+-K+ pump.
Reduction in the amount of oxygen necessary for the pump operation, results in reduction
of the resting membrane. When the resting membrane potential is reduced, the cell reach
threshold more rapidly and

becomes abnormally permeable to Na+ during action

potential phase 4, producing spontaneous depolarization.77-79, 81 Dysrhythmia that may
result from abnormal automaticity include premature atrial and ventricular extrasystoles
(PACs, PVCs, respectively), and idioventricular rhythms.77-79, 81
Triggered activity.
Triggered activity is an abnormal condition of pacemaker and myocardial nonpacemaker cells in which the myocyte depolarizes during action potential phase 2, phase
3, or phase 4 after repolarization is complete.77-79, 81 Resulting beats are called triggered
beats as they are triggered by prior beats. Triggered activity is characterized by the
occurrence of afterdepolarization. Afterdepolarizations that develop during phase 2 or 3
are called early afterdepolarization (EAD) and those that develop in phase 4 after
repolarization is complete are called delayed afterdepolarization (DAD).77-79, 81
Early afterdepolarization that occurs during phase 2 or early in phase 3 results
from activation of slow calcium channels. While EAD that occur late during phase 3
results from large inward Na+ currents generated by calcium overload. 82, 83 Once an EAD
reaches threshold, a second early beat “i.e., triggered beat” arises as result of preceding
action potential. Each triggered beat may precede another abnormal impulse resulting in
several abnormal beats.
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Early afterdepolarization can develop under conditions of hypoxia, acidosis,
hypokalemia, hypomagnesemia, hypothermia, high PCO2, and high concentrations of
catecholamines, and develops in areas of stretch or mechanical injury.

Early

afterdepolarizations are more likely to give rise to serious dysrhythmias such as long QT
syndrome, torsades de pointes, and polymorphic ventricular tachycardia.77-79, 81
High concentrations of catecholamines, digitalis, and hypokalemia trigger
development of DAD and cause serious arrhythmias such as accelerated junctional
rhythm and ventricular tachycardia in singles, pairs or paroxysms.77-79, 81
Reentry.
Reentry, a type of conduction abnormality, occurs when an impulse enters and
reenters a previously depolarized area and depolarizes it again. 82, 83 The path over which
the impulse travels to excite and re-excite a portion of cardiac tissue is called re-entrant
circuit.

Reentry is the mechanism of the vast majority of clinically relevant

tachyarrhythmias.77-79,

81

Reentry occurs in areas of unidirectional block, in which

impulses conduct in one direction and reenter it again with low velocity to continue
propagation in a circular manner, resulting in a run of premature beats or sustained
tachycardia.
Conditions that induce reentry can be grouped under: 1) shortening of cell
refractoriness caused by sympathetic stimulation, 2) lengthening of the conduction
pathway such as in hypertrophy, and 3) slowing of impulse conduction as manifested
during ischemia.77-79,

81

Clinical arrhythmias that are caused by reentry mechanism

include ventricular tachycardia, atrial fibrillation, atrial flutter, and Wolff- ParkinsonWhite syndrome.
Stretch and mechano-electrical feedback mechanism.
Mechano-electrical feedback is a term that describes electrophysiological changes
caused by regional mechanical stretch or global hemodynamic over-load mediated by
stretch- activated ion channels.

The mechano-electrical feedback mechanism is

characterized by shortening of action potential duration, a decrease in the resting diastolic
potential, and development of EAD and ectopic beats.
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The mechano-electrical feedback mechanism may play a role in arrhythmogenesis
in patients with impaired ventricular function or in regionally or globally impaired dilated
hearts or in hearts subject to pressure /volume overload or failure.85-89
In general, arrhythmogenic conditions, such as hypoxemia, hypercarbia, acidosis,
hypokalemia, hypomagnesemia, high concentrations of catecholamines and digitalis,
myocardial stretch or mechanical injury trigger the mechanisms of abnormal automaticity,
triggered activity and reentry.82, 83, 90, 91
Heart rate variability
The autonomic nervous system (ANS) is an important component of the
physiology of heart rhythm. A link between ANS alteration, specifically increased
sympathetic activity and decreased parasympathetic activity (as reflected by decreased
HRV), and the occurrence of dysrhythmias was demonstrated in numerous experimental
and clinical studies.35-42, 44, 92
Heart rate variability is the analysis of beat-to-beat variation in heart rate.
Variability of heart rate results, in large part, from ongoing changes in sympathetic and
parasympathetic inputs to the SA node.
Heart rate variability is a noninvasive indicator of autonomic neural regulation of
the heart,93 and is used as a valuable diagnostic and risk stratifying strategy in patients
with cardiac diseases as well in normal populations. Decreased HRV has been associated
with increased mortality in patients with heart failure,94 and acute myocardial
infarction.95, 96 In addition, HRV is considered a powerful predictor of sudden cardiac
death and dysrhythmic events in patients with underlying cardiac dysfunction.37, 42, 43, 97, 98
Heart rate variability and weaning from mechanical ventilation.
Respiratory sinus arrhythmia (RSA) is a normal phenomenon that refers to the
cyclical variation in heart rate during the respiratory cycle, such that the heart rate
accelerates during inspiration and slows during expiration. Sinus arrhythmia is mainly
mediated through changes in efferent vagal activity. Vagal activity is influenced by
stretch receptors in the lung and by baroreceptors located in the carotid sinuses and aortic
arch. Lung inflation that occurs during inspiration stimulates the vagal nerves in the lung
and induces a reflex tachycardia. During expiration, increases in blood pressure stimulate
baroreceptors and hence reflex bradycardia is seen.99
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Weaning, the process of transition from MV to spontaneous ventilation, is
associated with alterations in ANS tone, reflected by decreased HRV especially in
patients with underlying cardiovascular dysfunction and impaired compensatory
mechanisms. Alteration in HRV during weaning and its relation to weaning outcome was
investigated in both animals and human subjects. Shen et al.34 analyzed HRV in 24
patients during transition from pressure support ventilation (PSV) to spontaneous
breathing trial (SBT). The investigators found a significant decrease in LF and HF HRV
in the group of patients who failed the weaning process, but not in the success group. In
animal study, Frazier et al.33 found a significant increase in VLF power and a significant
decrease in HF power with exposure to a combination of pressure support and continuous
positive airway pressure (PS+CPAP) in a group of six canines. The reduction in HF
power could be explained as a result of the withdrawal of parasympathetic nervous
system activity, increased respiratory rate and decreased tidal volume that occur during
weaning. Frazier et al.100 demonstrated that patients who failed their initial weaning trial
had reduced HRV during ventilation and further decreased HRV during the weaning trial.
Heart rate variability and dysrhythmias.
Numerous investigators have demonstrated a significant relationship between
reduced HRV, genesis of malignant ventricular dysrhythmias (Primarily ventricular
fibrillation and ventricular tachyarrhythmias), and mortality.

35, 41-43, 45, 101

Clinical

researchers have shown reduced HRV with a shift toward sympatho-vagal imbalance
(i.e., increased sympathetic and/or reduced vagal tone) to occur before the expression of
dysrhythmias.39, 40
An increase in parasympathetic tone is considered a protective mechanism for the
heart. Increases in sympathetic tone are strongly associated with the genesis of
ventricular dysrhythmias caused by the three electrophysiologic mechanisms: reentry,
triggered activity, and automaticity.
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Most studies that describe a relationship between reduced HRV and occurrence of
cardiac dysrhythmias were limited to patients with cardiovascular diseases especially
heart failure, acute myocardial ischemia and myocardial infarction.

35, 36, 102

Studies have

shown that imbalances toward adrenergic predominance are associated with susceptibility
to dysrhythmia.35, 36, 102 That is because sympathetic stimulation decreases ventricular
refractoriness and increases myocardial excitability.
Numerous investigators reported significant alterations in ANS balance, with a
shift toward increased sympathetic activity or decreased parasympathetic activity or both,
and initiation of ventricular arrhythmias. Huikuri et al.103 reported a significant decrease
in HF power one hour preceding the onset of the ventricular tachycardia in patients with
ischemic heart disease. Fei et al.39 reported a significant increase in the LF/HF ratio
immediately before the onset of ventricular tachycardia episodes. The investigators
attributed the increase in the LF/HF to the decrease in parasympathetic activity rather
than enhanced sympathetic activity in patients with heart diseases. In contrast, Hayashi et
al.40 reported that the increase in the LF/HF before the onset of ventricular tachycardia
was attributed to the sympathetic dominance in patients without structural heart diseases.
Several studies have shown a shift toward an increase in sympathetic tone or a loss of
vagal tone before occurrence of paroxysmal atrial fibrillation36, 102 and atrial flutter

104

in

patients with underlying heart diseases.
Heart rate variability measurement.
The analysis of HRV is usually performed using commercial software. After
appropriate confirmation of heart beats obtained with Holter recordings and filtering
artifacts, a series of RR intervals (RR tachogram) is used to quantify HRV.105 The RR
interval (sometimes called normal-to-normal [NN] interval) is the time interval between
the R waves of two consecutive normal beats. Traditionally, two major approaches are
often used to measure HRV, time domain and frequency domain analyses.

Several

investigators used these two methods as complementary to each other.
Time domain analysis.
Time domain analysis is the simplest to perform. It is based on the statistical
calculations of standard deviation of NN intervals, coefficient of variance, short-and
long-term components of HRV. Time domain measures of HRV are defined in Table 2.1
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according to the recommendations of a Task Force Committee.106 Commonly used time
domain measures include standard deviation of normal RR interval (SDNN), the standard
deviation of the average of NN intervals in all 5 min segments of the entire recording
(SDANN), the square root of the mean of the sum of the squares of differences between
adjacent NN intervals (MSSD), and the percentage of successive normal RR intervals
that change by more than 50 ms compared to the total number of RR intervals (pNN50).
Table 2.1: Time domain measures of heart rate variability
Variable
Statistical measures
SDNN [ms]
Standard deviation of all NN intervals
SDANN [ms]
Standard deviation of the average of NN intervals in all 5 min
segments of the entire recording
RMSSD [ms]
Square root of the mean of the sum of the squares of
differences between adjacent NN intervals
SDNN index [ms]
NN50 count
pNN50 [%]
Triangular index

Mean of the standard deviations of all NN intervals for all 5
min segments of the entire recording
Number of pairs of adjacent NN intervals differing by > 50
ms in the entire recording
NN50 count divided by the total number of all NN intervals
Total number of all NN intervals divided by the height of the
histogram of all NN intervals measured on
discrete scale with bins of 1/128 s

Frequency domain analysis. Frequency domain analysis, or spectral analysis of
HRV, is a technique that provides distinct measures of the vagal as well as the
sympathetic modulation of the heart. Frequency domain measures of HRV are defined in
Table 2.2 according to the recommendations of a Task Force Committee.106
Table 2.2: Frequency domain measures of heart rate variability
Variable
Statistical measures
Total power [ms2]
Variance of all NN intervals
2
ULF [ms ]
Power in the ultra low frequency range (≤0.003 Hz)
VLF [ms2]
Power in the very low frequency range (0.003–0.04
Hz)
LF [ms2]
Power in the low frequency range (0.04–0.15 Hz)
2
HF [ms ]
Power in the high frequency range (0.15–0.4 Hz)
ULF= Ultra low frequency; VLF= Very low frequency; LF= Low frequency; HF= High
frequency
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The technique of power spectral analysis involves decomposing the heart rate
signal into a sum of sine waves as a function of frequency. The squared amplitude (i.e.,
power) of spectral components are displayed on a plot in which the power spectral
density (PSD) of HRV versus frequency are poltted.106 The total area under the curve of
the PSD versus frequency plot is equal to the total statistical variance, or the power of the
signal. These power distributions are calculated for defined frequency bands (Figure 2.1)
and are interpreted as an estimate of the variance of the HRV signal within the bands of
HF, LF, VLF, and ULF.44, 106 The HF component (0.15-0.40 Hz) represents the vagal
control to the heart,93 modulated by respiration.107-109 The LF (0.04-0.15Hz) component is
more controversial and has contribution from both, vagal and sympathetic modulation of
the heart.94, 108, 110 But, many investigators proposed the LF as an index of sympathetic
modulation.93 Very low frequency power (0.003–0.04 Hz) represents the sympathetic
activity. The ratio of LF to HF (LF: HF) is used as an index of sympatho-vagal balance
of the ANS.93, 106, 111 Short term recordings (up to 5 minutes) yield 3 peaks which are high
frequency (HF), low frequency (LF), and very low frequency (VLF). While long term
measurement (24 hrs) allows the measurement of ultralow frequency (VLF).
Figure 2.1: Power spectral analysis of heart rate variability at baseline for one
subject enrolled in the study
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The PSD can be estimated using a parametric (autoregressive [AR]) or a
nonparametric (Fast Fourier transform algorithm [FFT]) method.106 The FFT is easier to
use and it requires a priori selection of the frequency range of bands of interest.112
In summary, findings from clinical studies suggested that the ANS status is a
major determinant and a contributing mechanism in the generation of cardiac
dysrhythmias. Sympathetic activation and/or vagal withdrawal reflected as reduced HRV
increased the risk of developing lethal dysrhythmias. Measurement of HRV provides
significant information concerning the sympatho-vagal balance in the control of
cardiovascular function.
Weaning from Mechanical Ventilation
Mechanical ventilation is widely used to support ventilatory function in critically
ill patients. However, prolonged MV is associated with a variety of risks and
complications, which are associated with high morbidity and mortality rates, increased
hospital and ICU length of stay, and costs.1, 113 Therefore, weaning from MV as early as
possible is an important goal for mechanically ventilated patients.
The appropriate time of weaning should be selected carefully. Needless and long
MV increases the risk of ventilator-associated pneumonia, increased ICU length of stay,
and mortality. Alternatively, premature weaning imposes severe stress on the respiratory
and cardiovascular systems, which is associated with high complication rate, morbidity,
and mortality.8, 114
Weaning is the process during which MV is gradually withdrawn and
spontaneous breathing is resumed. This process represents approximately 41% of the
total time spent on MV.1, 115 At the 5th International Consensus Conference in Intensive
Care Medicine, Tobin116 described the weaning process as a continuum consisting of a
series of six stages lasting from intubation until hospital discharge.
As a brief description of this process, weaning from MV begins with treatment of
acute respiratory failure (stage 1). When the underlying cause of acute respiratory failure
stabilizes or significantly improves, the potential for weaning is considered (stage 2) and
daily assessment of the patient’s readiness for ventilator discontinuation is considered
(stage 3). Patients who meet the criteria for readiness to wean go through a spontaneous
breathing trial (SBT) (stage 4). Those who can tolerate the trial and are able to follow
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commands are extubated (stage 5), while those who cannot are returned back to full
ventilatory support for at least 24 h before performing a new trial. Patients who are
extubated and cannot maintain spontaneous breathing for 24 to 72 hours after extubation
are reintubated (stage 6).
Until recently, the decision to wean was based on physician’s judgment and
clinical experience. In the last few years, numerous clinical trials were conducted to
establish evidence-based protocols to standardize the process of weaning. In some ICUs,
protocols driven by respiratory therapists or ICU nurses are used for daily assessment to
determine when patients are ready to start the weaning process. Compared to traditional
care, weaning protocols resulted in better outcomes in some studies, such as significant
decreases in the duration of MV, ventilator-associated pneumonia, weaning time,
complication rate, ICU length of stay, costs, reintubation rate, and use of sedative
infusion.9, 117-120
Spontaneous breathing trials.
Implementing an evidence-based weaning protocol involves two major steps: 1)
daily assessment of readiness to wean; and 2) performing a SBT (Figure 2.2).
A SBT is an assessment test to determine if a patient needs to be continued on
MV or can be successfully extubated.18 A SBT should be considered as soon as the
patient meets the criteria for readiness to wean.
Clinical criteria to determined readiness for weaning were recommended by the
multisociety-sponsored evidence- based task force

18

and include (1) evidence of lung

injury resolving or stabilizing; (2) adequate oxygenation, (SpO2 ≥ 90% with PEEP <5 to
8 cmH2O, FiO2 <0.4 to 0.5); (3) stable hemodynamics with minimal or no pressor
treatment; and (4) ability to initiate spontaneous breathing effort.
Patients who meet the criteria of readiness to wean, undergo a SBT. The SBT can
be conducted using low levels of pressure support (5 to7 cmH2O), continuous positive
airway pressure (CPAP), or a T-piece with supplemental oxygen
for at least 30 minutes, but no longer than 2 hours.18, 122
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9, 10, 18, 121, 122

and lasts

During the SBT, the patient’s respiratory pattern, hemodynamic status and
comfort are monitored continuously. Although not all weaning protocols have the same
guidelines, Many protocols consider the SBT successful if the patient has a PaO2/FiO2 ≥
150 to 200, PEEP ≤ 6 cm H20, rapid shallow breathing index (RSBI) < 105, and stable
hemodynamics with no or minimal vasopressors. Patients who successfully complete a
SBT are considered for extubation if they are awake, able to protect their airway,
demonstrate effective coughing strength and have minimal need for suctioning.122
Weaning success is defined as extubation, and spontaneous breathing with no ventilatory
support for 48 hours following extubation.
Conversely, the SBT is defined as a failure if the patient experiences sustained
tachypnea (RR > 35 breaths/min), respiratory distress, decreased oxygen saturation (SpO2
< 90% with FiO2 > 50%), RSBI >105, increase of heart rate > 20 beats/minute above
baseline or systolic BP > 20 mmHg above baseline, new dysrhythmias, respiratory
acidosis, agitation, diaphoresis, and depressed mental status.122, 123 Those patients who
fail a SBT are returned to full ventilatory support for at least 24 hours for respiratory
muscle rest. Causes that contributed to weaning failure are identified and treated before
performing another trial. Weaning failure is defined as a failed SBT and/or reintubation
within 24-72 hours following planned extubation.122
Reintubation is considered if patients experience a decline in mental status,
respiratory failure, or significant hemodynamic instability.123,
extubation failure and reintubation are
pneumonia,

123

124

Unfortunately,

associated with high risk of nosocomial

hospital mortality, prolonged ICU and hospital stays, increased need for

tracheostomy and long term acute care.8, 114, 115
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Modes of weaning from Mechanical Ventilation.
Several modes and techniques are used to facilitate weaning including
synchronized intermittent mandatory ventilation (SIMV), T-piece, CPAP and pressure
support ventilation (PSV).115 Synchronized intermittent mandatory ventilation is a
ventilatory and weaning mode in which a preset of volume or pressure mandatory breaths
are delivered in coordination with patient’s spontaneous breaths effort (i.e., patient
triggered). If the ventilator was not triggered by the patient, mandatory breaths are
delivered according to the set rate. The goal of SIMV weaning is to gradually decrease
the number of breaths delivered by the ventilator, allowing the patient to take more
breaths of his or her own.7
Pressure support ventilation is a form of assisted ventilation, often used to
decrease work of breathing. With PSV, the patient triggers the ventilator and the
ventilator delivers a preset pressure of gas. Weaning using PSV consists of setting the
inspiratory pressure and PEEP to achieve a spontaneous tidal volume of 10-12 ml/Kg;
and the patient regulates the respiratory rate and tidal volume. During weaning, the
pressure support level is decreased gradually according to patient’s tidal volume and
respiratory rate.7 Pressure support ventilation is used during the weaning process in
around 26% of patients. 115
T-piece trials consist of alternating intervals of time on the ventilator with
intervals of spontaneous breathing. A T-piece circuit consists of a T-shaped tube that is
attached to the endotracheal or tracheostomy tube. One end of the tube is attached to an
oxygen flow meter and the other end is open. The goal of using a T-piece is to administer
supplemental oxygen while gradually decreasing the amount of time spent off the
ventilator.7
Several investigators reported and compared the rate of weaning success, length
of ventilation and duration of weaning attempts using different weaning modes. Brochard
et al.125 randomly assigned 456 patients to be weaned with PSV or SIMV, or T-piece.
They found that patients exposed to PSV had shorter duration of weaning compared to
the patients in the other two groups. Matic et al.63 randomly assigned 260 patients to a 2hour weaning trial using T-tube (n=110) or PSV (n=150). The investigators reported that
80 (73%) patients in the T-tube group and 120 (80%) patients in PSV group were
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successfully weaned and extubated. In patients with weaning difficulties, length of
ventilation, time of weaning, and length of stay was significantly shorter (p<0.001) in
patients who underwent a PSV trial. Esteban et al.9 found that one daily trial or multiple
daily trials of weaning using T-piece in 130 patients who failed the initial SBT
considerably reduced the duration of weaning than either SIMV or PSV. Applying CPAP
during spontaneous breathing improves right and left ventricular performance by
decreasing its afterload, and improves oxygenation. Squadrone et al. 126 observed in a
multicentre randomized controlled trial, that patients who developed severe hpoxemia
after abdominal surgery and received CPAP plus oxygen therapy had lower rate of
reintubation, occurrence of pneumonia, infection, and sepsis compared to oxygen
supplementation alone. In conclusion, there is no better weaning mode. Weaning mode
should be selected by physicians and respiratory therapists according to patient’s status
and needs.
Predictors of weaning outcome.
A number of parameters have been found to be associated with success or failure
of ventilator discontinuation.127 Some of these parameters were considered as predictors
by several investigators. Predictors include age, medical diagnosis, hemodynamics, lung
mechanics, gas exchange, severity of illness, duration of ventilation prior to weaning, and
symptoms of diaphoresis and agitation. The relevance and significance of these predictors
vary among different patient populations.
Several investigators reported some measurable parameters as significant
predictive indices of weaning outcome. Some of these indices include PaO2/FiO2,
respiratory system static compliance, maximum inspiratory pressure (MIP), mixed venous
oxygen saturation (SvO2),75 work of breathing (WOB), gastric mucosal pH,128 rapid
shallow breathing index (RSBI),

acute physiology and chronic health evaluation

(APACHE score), and arterial blood gases.122 For the purposes of this study, we focused
on RSBI and severity of illness upon ICU admission as measured by APACHE score.
That is because some investigators reported that RSBI >100 breaths/min/L
high APACHE score129, 131 are significant predictors of weaning failure.
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129, 130

and

The RSBI is the ratio of respiratory frequency to tidal volume (f/VT) calculated
during spontaneous breathing. The RSBI is affected by patient’s underlying
cardiovascular and respiratory status. Several investigators studied the significance of
RSBI as a predictor of weaning outcome in different patient populations and
controversial results were found. Some investigators reported that RSBI value <100–
105 breaths·min–1·L–1 predicts a successful SBT with a reported sensitivity of 0.97 and
specificity of 0.64.132 while a value of >100 breaths/min/L129, 130 predicts failed weaning
trials. Other investigators reported that RSBI was not a significant predictor of weaning
failure.122, 133, 134
The APACHE is a severity-adjusted methodology that predicts outcomes for
critically ill adult patients. Twenty seven variables are collected for each patient. These
variables include the diagnosis, age, vital signs (temperature, mean arterial pressure, heart
rate, respiratory rate), and laboratory values (such as serum potassium, creatinine,
albumin, bilirubin, white blood cell count, and hemtocrit). These data, in conjunction
with comorbidities, are combined and used to formulate a predictive equation for each
individual patient. These predictions are made for mortality (both ICU and hospital),
length of stay (both ICU and hospital), ventilatory days, and the need for active
treatment.135-138
The APACHE IV score (range 0-299) is formed by the sum scores of the acute
physiology score (range from 0-252), chronic health score (range from 0-23) and age
score (range from 0-24). The acute physiology score is the total number of points that the
patient earns from disturbed physiology alone. Chronic health includes more than thirty
chronic health items that affect the immune system. Some of these chronic health items
include AIDS, acute or chronic myelogenous or lymphocytic leukemia, multiple
myeloma, non-Hodgkin’s lymphoma, solid tumor with metastasis, presence of an
immunocompromised state (secondary to chemotherapy, radiation, or drug therapy),
hepatic failure with cirrhosis and jaundice and ascites, UGI bleeding, encephalopathy, or
coma, and diabetes mellitus.
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Physiological determinants of weaning outcome.
Weaning success is defined as extubation and spontaneous breathing with no
ventilatory support for 48 hours following extubation.9 Conversely, weaning failure is
defined as a failed SBT and/or reintubation within 24-72 hours following extubation.122,
139

Weaning failure occurs as a result of respiratory drive failure, impaired lung

mechanics, diaphragmatic dysfunction, hypoxemia,75 cardiovascular dysfunction, sepsis,
and positive fluid balance in the 24 hours before weaning,130 in addition to airway
obstruction or excessive secretions and pneumonia.123 Extubation failure may also be
related to the same reasons.
Unfortunately, failed weaning trials and failed extubation, ultimately prolong the
duration of MV. Up to one-third of patients experience difficult and prolonged weaning.
Prolonged MV is defined as patients’ need to ventilatory support for >72 hours or even
more.139, 140 Patients with difficult and prolonged weaning have higher incidence of ICU
mortality than those patients who wean easily. The high mortality rate results from the
underlying disease and/or complications associated with MV, especially ventilatorassociated pneumonia.
Summary
Up to 90% of patients admitted to ICUs require MV. The use of MV is associated
with increased morbidity, mortality and greater financial costs. Thus, it is important to
discontinue MV as soon as feasible. However, weaning from MV can produce
hemodynamic alteration (i.e., intrathoracic vascular volume and flow), and alterations in
ANS (reflected by decreased HRV). Decreased HRV can cause dysrhythmias especially
in patients with underlying cardiovascular disease. Cardiac dysrhythmias can decrease
cardiac output, induce myocardial ischemia, worsen respiratory failure and thus
negatively affect length of MV.
There is paucity of research about cardiac dysrhythmias during weaning from MV
and its impact on length of MV. Studying and identifying cardiac dysrhythmias that occur
during MV and weaning, and determining the role that dysrhythmias might play in length
of MV are vital in order to provide appropriate care and management for mechanically
ventilated patients.
Copyright© Muna Hassan Hammash 2010
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CHAPTER III:
MATERIALS AND METHODS
Design
In this longitudinal, repeated measures design, we collected data to evaluate the
impact of changes in HRV during weaning from MV on the development of cardiac
dysrhythmias and the impact of cardiac dysrhythmias on length of ventilation. Data were
collected on the following variables: 1) HRV (measured by examination of the beat-tobeat variability of heart rate continuously collected using Holter recording techniques and
evaluated in the frequency domain); 2) dysrhythmias (measured by continuously
collected ECG data using Holter recording techniques); and 3) length of MV. Data were
measured for each subject at baseline during MV and during the initial weaning trial from
MV. Comparison of each subject’s baseline data with weaning data allowed each subject
to serve as their own control.
Sample and Setting
A convenience sample of 35 adult patients was enrolled from the medical
intensive care unit (MICU), surgical intensive care unit (SICU), cardiac care unit (CCU)
and trauma intensive care unit (TICU) at the University of Kentucky Chandler Medical
Center (UKMC), Lexington, Kentucky.
The MICU is an 8-bed unit. It provides care for a mean monthly census of 40
patients. About 67% of these patients required MV support during their ICU stay. The
CCU is an 8-bed unit. An average of 37 patients per month is admitted to the CCU.
Approximately, 44% of admitted patients required MV for an average of 6.1 days. The
SICU is a 6-bed unit. An average of 33 patients per month is admitted to the SICU.
Around 67% of admitted patients required MV for an average of 11.7 days. The TICU is
an 8-bed unit. An average of 35 patients per month received care in TICU. Around 64%
of admitted patients require MV for an average of 6.5 days.
Patients of both genders and all races/ethnicities who were 18 years of age or
older and received MV for a minimum of 24 hours via endotracheal tube were eligible to
be included. The exclusion criteria for this study were patients who: 1) had a myocardial
infarction within the past 3 months or were admitted with a myocardial infarction; 2)
were undergoing cardiac surgery or underwent cardiac surgery within the last 3 months;
3) had neurological trauma or stroke within the last 3 months or were admitted with
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neurological trauma or stroke; 4) were in atrial fibrillation or had bouts of atrial
fibrillation; 5) had a pacemaker or implanted cardioverter defibrillator; or 6) had a
pulmonary artery catheter or central venous catheter that was not in proper position as
confirmed by radiography. These exclusion criteria make patients more vulnerable to
develop dysrhythmias and induce changes in HRV because of their underlying disease
process, and not because of the effect of MV or weaning process.
Ethical Review
This study was approved by the Institutional Review Board (IRB) at the
University of Kentucky (Appendix A).
Measures
Dysrhythmias
The number of times the heart beats each minute and the rhythm of these beats,
were evaluated by analysis of cardiac electrical activity using a 3-lead, 24-hour ECG
Holter recorder (459 Del Mar, Irvine, CA) with leads I, II, and V2. Holter recordings were
scanned using a Del Mar Holter Analysis System (453A, Irvine, CA) in semiautomatic
mode with operator confirmation of all beat types. The timing of QRS complex onset, as
well as all beat types and artifact, were manually confirmed. Data about the number of
ventricular, and supraventricular ectopic beats; and number of episodes of ventricular
tachycardia/fibrillation, and atrial fibrillation/flutter were collected.
These dysrhythmias were chosen because of their potential for serious impact
upon hemodynamics and oxygen delivery and potential effect on weaning outcome and
length of MV. Number of occurrences of each type of dysrhythmias, with the exception
of atrial fibrillation/flutter and ventricular tachycardia, were referenced as beats per hour.
Episodes of atrial fibrillation/flutter and ventricular tachycardia/fibrillation were
referenced as present or not, and occurring after initiation of weaning or not.
Heart rate variability (HRV)
Heart rate variability refers to beat-to-beat fluctuations in heart rate and is a
noninvasive indicator of autonomic tone. Heart rate variability is a predictor of risk of
sudden cardiac death in patients with diabetes and myocardial infarction.141 For this study,
frequency domain measures were used to reflect HRV. Frequency domain analysis or
power spectral analysis decomposes a signal into a sum of sine waves of different
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amplitudes and frequencies, and then presents the squared amplitudes of the sine waves
as a function of frequency. The following spectral components were measured in this
study: high frequency (0.15 to 0.40 Hz) which represents an index of parasympathetic
activity; low frequency (0.04 to 0.15 Hz) which represents parasympathetic and
sympathetic inputs, and very low frequency component (< 0.04 Hz), which represents
sympathetic activity.
Using the Del Mar HRV analysis software, the recording periods were divided
into consecutive, non-overlapping 5-min epochs. Artifacts, atrial fibrillation/flutter and
abnormal complexes along with the preceding and succeeding R-R intervals were
excluded from the analysis and linear interpolation was used to estimate the instantaneous
heart function. Segments in which more than 80% of its R-R intervals were not normal
were excluded and a Hanning window applied. A fast Fourier transformation was then
done. Heart rate variability changes during weaning were assessed by averaging and
comparing power spectra from the 5-min epochs during 24 hour baseline period of MV,
and during the first two hours of the weaning process.
Length of ventilation
Length of MV was measured as the number of days the patient required MV. It
started upon intubation and ended with MV discontinuation either by extubation or by
receiving oxygen supplementation through tracheostomy. Data about length of ventilation
were abstracted from patient medical record and respiratory therapy records.
Socio-demographic characteristics and clinical data
Demographic data including age, gender, marital status, type of insurance,
ethnicity, height and weight were abstracted from the patient medical record .
Clinical data including the past and current history of MV, history of cardiac
diseases and dysrhythmias, reason of hospitalization, hospital and ICU length of stay
before intubation were collected at baseline upon enrolling the patient into the study.
Data about APACHE IV score, physiological status, pulmonary status, cardiovascular
status, and intake and output status were collected from the medical record twice, for
baseline during MV and for the weaning day (Appendix B).
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The institutional review board approval was obtained from the University of
Kentucky Medical Institutional Review Board for the conduct of this study. Each
morning, the PI evaluated all patients receiving MV for inclusion criteria. Candidate
patients who met the inclusion criteria were approached and recruited. The study purpose,
data collection protocol, risks and benefits were explained and discussed with a patient
surrogate. In this study, the patient surrogate provided the informed consent. The patient
was assessed daily for competence to provide informed consent during the study period.
Once the patient became competent, the study purpose, data collection protocol, risks and
benefits were explained for the patient in the presence of his/her surrogate, and oral
consent was obtained.
The data collection timeline is described in Figure 3.1. At baseline, upon
enrollment in the study, demographic and baseline clinical data were abstracted from the
medical record. Skin on the chest was prepared to attach the electrodes for Holter
monitoring. Preparation included carefully clipping of hair in areas where electrodes were
to be placed if needed and/or cleaning the skin with alcohol to remove skin oils.142 Holter
monitor electrodes for 3-leads were placed in the appropriate configuration as follows:
(1) left anterior axillary line, 6th rib; (2) two centimeters right of the xiphoid process on
the rib; and (3) left mid- clavicular line, 6th rib). Following visual confirmation of an
adequate signal, a 24-hour continuous ECG recording was started.
All patients enrolled in the study were evaluated every morning for readiness to
wean by respiratory therapists and an attending physician. Readiness to wean was
determined based on the following criteria: (1) resolution of the reason for which the
patient was intubated; (2) adequate oxygenation, (SpO2 ≥ 90% with PEEP <5 to 8
cmH2O); (3) stable hemodynamics with minimal or no pressor treatment; (4) pH > 7.35;
(5) patient temperature < 102 F; and (6) minimal to no sedation. Once the first weaning
trial was prescribed by the attending physician, the PI attached a Holter monitor device as
described earlier. ECG was continuously recorded during the weaning trial. Clinical data
collected at baseline were collected again during weaning from the medical record. All
data collection records and ECG records were coded by a subject number and stored in a
locked file cabinet at the College of Nursing research area.
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The PI reviewed all data forms for completeness and legibility to decrease
missing data and possible erroneous entries and other problems. All data were collected
on data forms developed by a team of researchers studying MV and weaning. All data
collected were kept in password-protected files, entered and organized in dated folders
stored on the College of Nursing secure server.
Figure 3.1: Data Collection Timeline

Baseline Data

Initial weaning trial

(Enrollment baseline)

Demographic data
Clinical data

Clinical data

Holter monitor (for 24 hours)

Holter monitor (for 2hours)

Heart rhythm

Heart rhythm

HRV

HRV

HRV = Heart rate variability
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Data Analysis
Before conducting analyses to test specific aims, data were cleaned. Frequency
distributions were developed for all variables to detect and correct erroneous codes.
Extreme, but possible codes were verified. Skewness and kurtosis were computed to
identify those variables that might benefit from transformation to reduce any marked
deviations from the normality assumptions of linear model analyses. Data analyses were
performed using SPSS for Windows, version 16.0 (Chicago, IL). Descriptive statistics
were used to characterize the sample. To further characterize the sample, repeatedmeasures analysis of variance was used to determine differences across time in the
variables of interest measured at baseline and during weaning. Differences were
considered significant at an a priori α level of .05 or less.
Specific Aim 1: To determine the relationship of ANS tone (reflected by HRV)
during weaning to the development of cardiac dysrhythmias after controlling for baseline
HRV measured during MV.
Multiple linear regression was used to determine the relationship of HRV during
weaning to the development of cardiac dysrhythmias. In order not to violate the
assumptions of multiple regression analysis, ratio scores of independent variables were
used to narrow the number of variables forced in each model. The ratio scores (i.e.,
average score at weaning divided by average score at baseline) of high frequency (HF),
low frequency (LF), and very low frequency (VLF) were regressed separately on the
mean score of occurrence of ventricular and supraventricular ectopic beats during
weaning after controlling for APACHE IV score during weaning. In previous published
studies, investigators used the value of APACHE score upon admission. In this study, the
value of APACHE IV score during weaning was used to evaluate its impact on data
collected during weaning. However, it is worthy to mention that there were no
differences in results obtained using either the value of APACHE score on admission or
during weaning. Separate models were developed to test the relationship of HRV during
weaning in the frequency domain (HF, LF, and VLF frequencies) with each of the
following outcomes: 1) number of ventricular ectopic beats per hour; and 2) number of
supraventricular ectopic beats per hour. No stepping procedure was used to test these
models.
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Specific Aim 2:

To determine the relationship between the occurrence of

dysrhythmias during weaning and length of MV. Pearson correlation coefficients were
computed length of MV, APACHE score at weaning, rapid shallow breathing index
(RSBI), cumulative fluid balance based on 24 hour intake and output, and PaO2/FiO2.
The length of MV was only correlated with APACHE score during weaning. Therefore,
the value of APACHE score during weaning was controlled for in multiple regression
models as described below.
Multiple linear regression was used to evaluate the predictive power of cardiac
dysrhythmias for length of MV, controlling for APACHE IV score during weaning.
Variables were entered in two blocks: 1) the first block contained the variable to be
controlled (APACHE IV score during weaning); and 2) the second block contained the
number of ventricular ectopic beats per hour, and the number of supraventricular ectopic
beats per hour separately. No stepping procedure was used to test these models.

Copyright© Muna Hassan Hammash 2010
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CHAPTER IV: RESULTS
Sample Characteristics
A total of 35 patients with a mean age of 53.3 years were enrolled in the study. Of
the sample, 23 (66.7%) were men, 34 (97%) were Caucasian, 17 (49%) were married, 23
(65%) were supported with government insurance, 11(31%) had a history of chronic
pulmonary disease, 12 (38%) had received MV during a previous hospital admission and
17 (49%) had a history of cardiovascular disease. Of those patients who reported the
presence of underlying cardiovascular disease, 16% had a history of cardiac dysrhythmias.
Patients enrolled in the study had different medical diagnoses upon admission such as
neoplasms, pulmonary diseases, gastrointestinal conditions, liver and kidney diseases.
Characteristics of the sample are summarized in Table 4.1.
The majority of patients (72%) were mechanically ventilated for pulmonary
conditions (e.g., acute respiratory distress syndrome, acute respiratory failure, pneumonia,
and aspiration). Of the 35 patients enrolled in this study, 3 patients (8.6%) died, and 2
patients (5.7%) required tracheostomy without a weaning trial. Two-thirds of the 30
patients 23 (77%) failed the initial weaning trial and underwent an average of 2.8
weaning attempts (range 0-11 trials) before successful weaning.

Patients were

mechanically ventilated an average of 11.6 ± 8.4 days and stayed in ICU an average of
15.6 ± 9.2 days.
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Table 4.1: Characteristics of the sample (n=35)
Characteristic

Frequency
(%)

Age, yr
Sex
Male
Female
Ethnicity
Caucasian
African- American
Marital status
Married
Single/divorced/widowed
Type of insurance
Government
Commercial and HMO
Self
History of pulmonary diseases
Yes
No
History of mechanical ventilation
Yes
No
History of cardiovascular disease
Yes
No
History of cardiac rhythm disturbances
Yes
No
Admission Diagnosis
Pulmonary diseases
Cardiac diseases
Liver and kidney conditions
Gastrointestinal conditions
Nervous system conditions
Trauma
Other

23 (66.7)
12 (34.3)
34 (97.1)
1 (2.9)
17 (48.6)
18 (51.4)
23 (65.7)
10 (28.6)
2 (5.7)
11 (31)
24 (69)
12 (37.5)
20 (62.5)
17 (49)
18 (51)
5 (16)
26 (84)
6 (17.4)
1 (2.9)
5 (14.5)
9 (26.1)
4 (11.6)
4 (11.6)
6 (17.4)
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Mean± SD OR
Median (25th,
75th percentile)
53.3 ±14.6
(Range 22-84)

Table 4.1 (Continued): Characteristics of the sample (n=35)
Characteristic
Frequency
(%)
Hospital length of stay prior to ICU admission, days
Hospital length of stay prior to intubation, days

Mean± SD OR
Median (25th,
75th percentile)
1 (0, 2)
(Range 0-52)
0 (0, 1)
(Range 0-52)

Reason for current ventilation
Pulmonary
Neurologic
Surgical
Results of initial weaning trials (n=30)
Success
Failure
Number of weaning trials (n=30)

25 (72.5)
4 (11.6)
6 (17.4)
7 (23)
23 (77)

Length of mechanical ventilation, days
Length of hospital stay, days
Length of ICU stay, days
Length of ICU stay prior to tracheostomy (n=7),
days

2.8 ± 2.6
(Range 0-11)
11.6 ± 8.4
(Range 2-33)
28.9 ± 21.9
(Range 9-101)
15.6 ± 9.2
(Range 3-46)
13.3 ± 6.9
(Range 5-23)

Changes in Clinical Characteristics
Clinical characteristics at baseline during MV and at the initial weaning trial were
compared using repeated measured ANOVA and are summarized in Table 4.2. Of the 35
patients enrolled in this study, 5 patients (3 died, and 2 required tracheostomy before
receiving any weaning trial) were excluded from further data analysis.

In addition,

because some laboratory data were not ordered similarly, numbers of patients available
for baseline and weaning data points were different across the variables.
Of those clinical variables compared (Table 4.2), the Glasgow coma score (GCS),
arterial oxygen saturation (SaO2), levels of calcium and magnesium, RBC count,
hemoglobin and hematocrit, and cumulative fluid balance on weaning day differed
significantly from those measured at baseline. The mean GCS increased significantly
from 8.7 at baseline to 10.3 at the time of weaning (p = 0.001), indicating an
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improvement in level of consciousness. The mean APACHE IV score at baseline was
69.8, demonstrating a high severity of illness in this sample. The mean APACHE IV
score on the weaning day (60.97) was not different of the value measured at baseline
(p= .07). The mean SaO2 increased significantly from 95.93% at baseline to 97.67% at
the time of weaning (p = 0.02). The baseline mean level of calcium (7.56 mg/dl) and
magnesium (1.83mg/dl) increased significantly to 7.89 mg/dl and 2.02 mg/dl,
respectively, at weaning time (p < 0.05). Also, RBC count, hemoglobin, and hematocrit
decreased significantly by the time of weaning trial (p = 0.05). On weaning day, mean
positive fluid balance was significantly higher than at baseline (15340 ± 13765 mL
versus 12364 ± 10559 mL, p < 0.05).
Table 4.2: Comparison of patient clinical data at baseline during MV and on the day
of initial weaning trial
Variable
n
Baseline MV
Weaning day
p
Mean ± SD
Range
Mean ± SD
Range
Patient’s
30 98.99 ± 1.41
96.298.96± 1.72
95.9-103.4 0.94
temperature,
101.8
F
Glasgow
30 8.7 ± 2.28
3-11
10.3 ± 1.26
6-14
0.00
Coma Score
1
APACHE IV 30 69.8 ± 25.7
26-125
60.97 ± 20.36
16-111
0.07
score
ABGs
pH
28 7.4 ± 0.08
7.21-7.55 7.41 ± 0.07
7.26-7.58 0.21
PaO2,
mmHg
PaCO2,
mmHg
Bicarbonate,
mmol/L
SaO2, %
Serum
glucose,
mg/dl
Serum
sodium,
mmol/L

28

97.3 ± 39.00

34-243

109.52 ± 35.59

34-179

0.12

28

35.3 ± 10.08

23-71

35.44 ± 10.26

18-69

0.93

28

21.22 ± 6.05

11-43

21.96 ± 5.71

12-42

0.25

28
30

95.93 ± 3.66
106.9 ± 17.81

87-100
77-155

97.67 ± 1.92
121.10 ± 47.47

93-100
62-282

.02
.12

30

138.97 ± 5.54

127-150

139.03 ± 4.14

131-148

.93
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Table 4.2 (Continued): Comparison of patient clinical data at baseline during MV
and on the day of initial weaning trial
Variable
n
Baseline MV
Weaning day
p
Mean ± SD
Range
Mean ± SD
Range
Serum
30 3.92 ± 0.61
2.9-5.7
3.9 ± 0.65
3-6.2
.83
potassium,
mmol/L
Serum
30 7.56 ± 0.77
5.3-9.3
7.89 ± 0.84
5.3-9.3
.02
calcium,
mg/dl
Serum
19 1.83 ± 0.44
1.3-3.6
2.02 ± 0.42
1.4-3.1
.007
magnesium,
mg/dl
Serum
18 3.93 ± 1.97
1.1-10.1
3.46 ± 1.18
1.9-6.2
.26
phosphorus,
mmol/L
Serum
29 109.68 ± 8.08 90-129
108 ± 7.21
91-120
.47
chloride,
mmol/L
Serum
30 1.86 ± 2.05
.43-9.80
1.55 ± 1.25
.44-5.89
.14
creatinine,
mg/dL
Blood urea
29 27.65 ± 28.02 5-138
27.17 ± 19.70
5-80
.41
nitrogen,
mg/dL
Serum
11
.28
1.80 ± 0.50
.9-2.7
1.96 ± 0.59
1-3.8
albumin, g/L
Serum total
11
.21
bilirubin,
2.69 ± 1.82
.3- 7.6
2.15 ± 1.44
.4- 5
g/dL
White blood 30 14.6 ± 7.55
1.5-32
12.77 ± 5.53
3.5-23.9
.09
cells, K/uL
Red blood
30
.04
3.36 ± 0.54
2.05- 4.68 3.18 ± 0.30
2.64- 3,78
cells, M/uL
Platelets,
30 180.07 ±
205.83
.44
34-483
18-962
K/uL
114.22
±180.62
Hemoglobin, 30
.05
10.11 ± 1.68
6.9-14
9.60 ± 0.94
7.8-11.4
g/L
Hematocrit,
30
20.3- 41.5
24- 33.2
.05
29.07 ± 4.75
28.04 ± 2.64
%
Cumulative
30
.03
12364.39 ±
-1431.40- 15340.06 ±
-528.40fluid balance,
10558.67
42406.00 13764.52
52804.00
mL
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Changes in Respiratory Mechanics
In this study, 27 patients out of 30 were exposed to a combination of PS (8-15 cm
H2O) and CPAP 5 cm H2O (PS+CPAP) during weaning trial. Three patients selfextubated and received supplemental oxygen through either a partial rebreathing or nonrebreathing mask.
Respiratory mechanics were measured at baseline during MV and during weaning
trial. Respiratory rate (total and spontaneous), peak and mean airway pressures were
significantly different from baseline values (Table 4.3). There was no differences in RSBI
for patients who failed weaning (57.05± 36.25), and patients who had successful weaning
trial (24.00± 7.94); t (21) = 1.54, p= .14.
Table 4.3: Comparison of respiratory characteristics at baseline during MV and
during the initial weaning trial
Variable
n
Baseline MV
Weaning
P
Mean± SD
(PS+CPAP)
Mean± SD
Vt, ml/min
25
526 ± 192.47
476.32 ± 151.26
.26
FiO2, proportion of 1.0
29
0.47 ± 15.38
0.42 ± 12.22
.14
Total RR, breaths/min
30
17.57 ± 4.85
21.73 ± 7.52
.01
Spontaneous RR,
30
3.63 ± 5.68
21.73 ± 7.52
< 0.001
breaths/min
PEEP, cm H2O
27
6.74 ± 4.71
5.00 ± 0.00
.06
Airway pressure
Peak
24
29.38 ± 8.88
18.13 ± 6.40
< 0.001
Mean
24
14.60 ± 9.17
9.34 ± 3.20
.007
Vt = Tidal volume; FiO2= Fraction of inspired oxygen; RR= respiratory rate; PEEP=
Positive end-expiratory pressure.
Changes in Cardiac Rhythm
Cardiac rhythm data were collected at baseline for 24- hours. During the initial
weaning trial, cardiac rhythm data were continuously recorded 1- hour before and during
weaning trial up to 24 hours. For the purpose of this study, data of cardiac rhythm was
reported for the first 2 hours after initiation of the first weaning trial. All subjects (n=35)
had complete electrocardiographic data at baseline. Two data records obtained during
weaning could not be analyzed because of high T wave amplitude. Electrocardiographic
data during weaning were collected from 25 patients only because 3 patients died, 2
patients had tracheostomy before weaning and 3 patients self extubated. In addition,
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weaning trials for another 2 patients were missed by the investigator. One patient had a
single episode of ventricular tachycardia during weaning; none had ventricular or atrial
fibrillation. All patients experienced either ventricular or supraventricular ectopic beats or
both. The mean supraventricular ectopic beats per hour during weaning was significantly
higher than the mean at baseline; the mean of ventricular ectopic beats per hour did not
change (Table 4.4).
Table 4.4: Comparison of cardiac rhythm at baseline during MV and during the
initial weaning trial (n=25)
Cardiac Rhythm
Baseline
Weaning
p
Mean ± SD
Mean ± SD
Mean supraventricular beats/hour
40 ± 82.16
366± 1726.32
< 0.001
Mean ventricular beats/hour
15 ± 37.4
14 ± 27.24
.68
Comparisons of the mean of supraventricular ectopic betas at baseline and during
weaning for all patients and per individual patients (n=25) are shown in Figures 4.1and
4.2 respectively. Comparisons of the mean of ventricular ectopic betas per hour at
baseline and during weaning for all patients and per individual patients (n=25) are shown
in Figure 4.3 and 4.4 respectively.
Figure 4.1: Comparison of mean supraventricular ectopic at baseline and during
weaning for all patients (n=25)
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Figure 4.2: Comparison of mean supraventricular ectopic at baseline and during
weaning per individual patients (n=25)

Figure 4.3: Comparison of mean ventricular ectopic at baseline and during weaning
for all patients (n=25)
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Figure 4.4: Comparison of mean ventricular ectopic at baseline and during weaning
per individual patients (n=25)

Changes in Heart Rate Variability (HRV)
The 5-min segments in which 80% of R-R intervals were normal were analyzed
for 22 patients at baseline during MV and during the initial weaning trial. Out of the 22
patients, 5 patients had a successful weaning trial and 17 patients failed the trial.
Compared to baseline values, there were no changes in very low frequency (VLF)
power and high-frequency (HF) power; but significant increases in low-frequency (LF)
with exposure to PS + CPAP during weaning trial (p ≤ 0.05) as shown in Table 4.5.
Table 4.5: Heart rate variability at baseline and during the initial weaning trial
(n=22)
Variable
Baseline
Weaning
p
Mean± SD
Mean± SD
VLF
79.41 ± 109.97
111.09 ± 139.64
.06
LF
82.86 ± 126.43
202.62 ± 391.27
.04
HF
78.84 ± 108.99
50.16 ± 71.85
.18
VLF= Very low frequency; LF= Low-frequency; HF= High-frequency
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Patients who had a successful weaning trial had no change in VLF, LF, and HF
power (Table 4.6). Patients who had a failed weaning trial had significant increases in LF
power and significant decreases in HF power (Table 4.7).
Table 4.6: Heart rate variability of patients who had successful weaning trial at
baseline and during weaning trial (n=5)
Baseline
Weaning
P
Mean ± SD
Mean ± SD
VLF
105.56 ± 142.66
63.46 ± 57.88
.39
LF
151.45 ± 221.09
109.98 ± 97.92
.62
HF
55.1 ± 55.54
104.49 ± 137.13
.33
VLF= Very low frequency; LF= Low-frequency; HF= High-frequency

Table 4.7: Heart rate variability of patients who failed the initial weaning trial at
baseline and during weaning trial (n=17)
Baseline
Weaning
P
Mean ± SD
Mean ± SD
VLF
72.88 ± 103.76
122.99 ± 152.24
.06
LF
66.96 ± 91.63
230.78 ± 433.92
.04
HF
107.81± 141.15
45.30 ± 55.08
.04
VLF= Very low frequency; LF= Low-frequency; HF= High-frequency
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Comparisons of HRV at baseline and during weaning for the whole sample
(n=22), and per individual patients are displayed in Figures 4.5 - 4.8.
Figure 4.5: Comparison of heart rate variability at baseline and during weaning for
all patients (n=22)

Figure 4.6: Comparison of VLF at baseline and during weaning per individual
patients (n=22)
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Figure 4.7: Comparison of LF at baseline and during weaning per individual
patients (n=22)

Figure 4.8: Comparison of HF at baseline and during weaning per individual
patients (n=22)
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Relationship of heart rate variability (HRV) during weaning to the occurrence of
cardiac dysrhythmias
Multiple regression analyses were separately conducted to test the potential
relationship between HRV and occurrence of ventricular and supraventricular ectopic
beats during weaning. The ratio scores (i.e., average score at weaning divided by average
score at baseline) of HF, LF, and VLF power were regressed separately on the mean
number of ventricular and supraventricular ectopic beats during weaning after controlling
for APACHE IV score on the day of weaning. In each hierarchical regression, APACHE
IV score was entered first, and each of the HRV components was entered last in order to
test their unique contribution to prediction.
Multiple linear regression analysis revealed that HRV in the HF power
significantly accounted for 68% of the variance in occurrence of ventricular ectopic beats
(β = .79, p = < .001) and for 29% of the variance in occurrence of supraventricular
ectopic beats during weaning (β = .53, p = .02) as shown in Tables 4.8 and 4.9
respectively. VLF accounted for 63% of the variance in occurrence of ventricular ectopic
(β = .776, p = < .001) as displayed in Table 4.10 VLF power was not found to explain a
significant amount of the variance in supraventricular beats during weaning (Table 4.11).
LF significantly accounted for 41% of the variance in occurrence of ventricular ectopic
beats (β = .60, p = .002), and 36% of the variance in occurrence of supraventricular
ectopic betas (β =.61, p = .002) during weaning (Tables 4.12 and 4.13).
Table 4.8: Multiple regression analysis of relationship between HF and occurrence
of ventricular ectopic beats during weaning (N=21)
Predictor
R2
Adj
R2
F
df
Sig. F
Standardized
variable
R2
change change
change ß
Step 1
.056 .006
.056
1.13
1,
.302
.213
APACHE IV
19
Step 2
.684 .649
.628
35.80
1,
< .001
.793
HF ratio
18
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; HF= High
frequency
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Table 4.9: Multiple regression analysis of relationship between HF and occurrence
of supraventricular ectopic beats during weaning (N = 20)
Predictor
R2
Adj
R2
F
df
Sig. F Standardized
2
Variable
R
change change
change ß
Step 1
.001
-.055
.001
.012
1, 18 .904
-.042
APACHE IV
Step 2
.285
.201
.285
6.78
1, 17 .02
.534
HF ratio
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; HF= High
frequency
Table 4.10: Multiple regression analysis of relationship between VLF and
occurrence of ventricular ectopic beats during weaning (N = 25)
Predictor
R2
Adj R2
F
df
Sig. F
Standardized
variable
R2
change change
change
ß
Step 1
.056 .015 .056
1.365
1, 23
.255
.076
APACHE IV
Step 2
.633 .599 .577
34.522 1, 22
< .001
.776
VLF ratio
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; VLF= Very low
frequency
Table 4.11: Multiple regression analysis of relationship between VLF and
occurrence of supraventricular ectopic beats during weaning (N = 24)
Predictor
R2
Adj
R2
F
df
Sig. F Standardized
2
variable
R
change change
change ß
Step 1
.001 -.045 .001
.015
1, 22 .904
-.252
APACHE IV
Step 2
.020 -.073 .020
.418
1, 21 .525
.647
VLF ratio
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; VLF= Very low
frequency
Table 4.12: Multiple regression analysis of relationship between LF and occurrence
of ventricular ectopic beats during weaning (N = 25)
Predictor
R2
Adj R2
F
df
Sig. F
Standardized
variable
R2
change change
change ß
Step 1
.056 .015 .056
1.365
1, 23 .255
.140
APACHE IV
Step 2
.406 .352 .350
12.96
1, 22 .002
.600
LF ratio
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; LF= Low frequency
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Table 4.13: Multiple regression analysis of relationship between LF and occurrence
of supraventricular ectopic beats during weaning (N = 25)
Predictor
R2
Adj
R2
F
df
Sig. F
Standardized
2
variable
R
change change
change
ß
Step 1
.001
-.045 .001
.015
1, 22
.904
-.126
APACHE IV
Step 2
.360
.298
.359
11.750 1, 21
.002
.608
LF ratio
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; LF= Low frequency

Relationship of the occurrence of dysrhythmias to length of mechanical ventilation
Pearson correlation coefficients were computed among length of MV, APACHE
IV score at weaning, rapid shallow breathing index (RSBI), cumulative fluid balance
based on 24 hour intake and output, and PaO2/FiO2 (Table 4.14). Length of MV was
correlated significantly with APACHE score only (r = .369, p < .05).
Table 4.14: Correlation between length of MV, APACHE score, RSBI, fluid status,
and PaO2/FiO2 at weaning (n=25)
1
2
3
4
5
*
1. Length of MV
--.369 .004
.296
-.019
2. APACHE score
---.246 .077
.092
3. RSBI
---.149 -.149
4. Cumulative fluid balance
--.077
5. PaO2/FiO2 at weaning
--MV = Mechanical ventilation; APACHE IV= Acute Physiology and Chronic Health
Evaluation IV; RSBI= Rapid shallow breathing index
*
p < .05, two tailed
The mean number of ventricular and supraventricular ectopic beats during
weaning was regressed separately on the mean time the patient received MV after
controlling for APACHE IV score on the day of weaning; results are displayed in Tables
4.15 and 4.16.
Multiple

linear

regression

analysis

revealed

that

the

occurrence

of

supraventricular ectopic beats during weaning accounted for 18% of the variance of the
time patient spent on MV (β = 2.3, p = .032) as shown in Table 4.15. The occurrence of
ventricular ectopic beats during weaning did not explain a significant amount of the
variance in time patient spent on MV (Table 14.16).
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Table 4.15: Multiple regression analysis of relationship between occurrence of
supraventricular ectopic beats during weaning and length of MV (N=24)
Predictor
R2
Adj R2
F
df
Sig. F
Standardized
2
variable
R
change change
change ß
Step 1
.130 .090 .130
3.275
1, 22 .084
.863
APACHE IV
Step 2
.305 .239 .176
5.308
1, 21 .032
2.304
Mean number
of SVE/hr
MV = Mechanical ventilation; APACHE IV= Acute Physiology and Chronic Health
Evaluation; SVE=Supraventricular Ectopic Beats
Table 4.16: Multiple Regression Analysis of relationship between occurrence of
ventricular ectopic beats during weaning and length of MV (N=26)
Predictor
R2
Adj
R2
F
df
Sig. F
Standardized
2
variable
R
change change
change ß
Step 1
.130 .094
.130
3.589
1, 24 .070
1.929
APACHE IV
Step 2
.143 .069
.013
.350
1, 23 .560
.592
Mean number
of VE/hr
MV = Mechanical ventilation; APACHE IV= Acute Physiology and Chronic Health
Evaluation; VE= Ventricular Ectopic Beats
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CHAPTER V: DISCUSSION
Discussion of Findings
These data supported the hypotheses that: 1) HRV measured in the frequency
domain during weaning was related to the occurrence of cardiac dysrhythmias; and 2)
rate of supraventricular ectopic beats per hour during weaning was an independent
predictor of length of MV.
Our study results showed that exposing patients (n=22) to a combination of PS10
cm H2O and CPAP 5 cm H2O during weaning generated a significant increase in LF
power with no change in VLF or HF power compared to baseline. Our study findings
were in partial disagreement with Frazier at al.

33

findings. Frazier et al.33 reported a

significant increase in VLF power and a significant decrease in HF power with exposure
to a combination of PS 10 cm H2O and CPAP 10 cm H2O in a group of six anesthetized
canines with normal ventricular function studied in a laboratory setting. The
disagreement can be attributed to the underlying cardiac function of subjects enrolled in
each study and the degree of positive ITP achieved during weaning. The use of
PS+CPAP during weaning produces positive ITP. Positive ITP decreases the pressure
gradient between the vena cava and right atrium, which in turn decreases venous return
and RV preload. The higher level of positive ITP pressure achieved during weaning is
accompanied by further reduction in RV preload in subjects with normal cardiac function
as found by Frazier et al.33 As a result, the ANS compensated by increasing sympathetic
tone (reflected by VLF power) and decreasing parasympathetic tone (reflected by HF
power)

33

in order to maintain adequate cardiac output and oxygen delivery. The ANS

adaptive response can be significantly altered in presence of impaired cardiac function as
demonstrated by our findings. In our study, 49% of patients were known to have impaired
cardiac conditions. The acute fluid shift during weaning can be challenging for these
patients, which explains dominance of sympathetic tone activity in our study
demonstrated by increased LF power.
Although the potential anxiety and stress that patients experience during weaning
from MV was not measured in this study or any previous published studies, stress and
anxiety are known to further augment activation of sympathetic tone. The effect of
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emotional stress was removed in Frazier et al.

33

study as their study was conducted in a

controlled laboratory setting and the subjects were anaesthetized.
In the current study, patients were separated into two groups based on initial
weaning trial outcome. Patients who experienced a successful weaning trial (n=5)
exhibited no change in VLF, LF, and HF power, while patients who failed the weaning
trial (n=17) exhibited increases in LF power and decreases in HF power compared to
baseline. Changes in HRV exhibited by the two groups were in partial agreement with
Shen et al.34 findings. Shen et al.34 analyzed HRV for 24 patients during weaning from
MV during the transition from pressure support ventilation (PSV) to SBT (using a Tpiece trial), and found a significant decrease in LF and HF in patients who failed a
weaning trial (n=12), but not in the success group. Although Shen and associates study
and our study were conducted in ICU settings, differences in HRV findings in patients
who failed a weaning trial can be attributed mainly to differences in design of the studies
and methodologic factors. Shen and associates started HRV measurement 10- minutes
after transition from (PSV) to SBT (T-piece trial), excluded patients who had frequent
cardiac arrhythmias (defined as > 10% of nonsinus beats), and excluded the 5-minute
segment in which more than 90% of the R-R intervals were not normal-to-normal (N-N)
intervals from analysis. In our study, HRV measurement started upon exposure to
PS+CPAP trial, only patients with atrial fibrillation/ flutter at baseline were excluded,
and the entire 5-minute segment in which more than 80% of the R-R intervals were not
normal-to-normal (N-N) intervals were excluded from analysis. In addition, patients
enrolled in Shen and associates study were older than patients in our study (69.8 ± 17.8)
vs. (53.3 ±14.6). Older age can explain the decrease in ANS adaptive response and the
decrease in HRV measurements in Shen and associates study.143 Medications and
underlying disease can have an impact on HRV analysis. However, these two factors
were not evaluated in either study.
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Changes in HRV that occurred during weaning may have influenced the
occurrence of cardiac dysrhythmias, especially in patients with underlying cardiac
dysfunction. Numerous studies have reported a significant relationship between reduced
HRV and the genesis of malignant ventricular dysrhythmias, primarily ventricular
fibrillation and ventricular tachyarrhythmias, especially in patients with heart failure,
myocardial ischemia, and myocardial infarction. 35, 41, 42, 45, 101
Several studies have shown imbalances that included increased sympathetic
activity or decreased parasympathetic activity or both before occurrence of paroxysmal
atrial fibrillation

36, 102

and atrial flutter104 in patients with underlying heart diseases.

Huikur i et al.103 reported a significant decrease in HF power one hour before occurrence
of ventricular tachycardia in patients with ischemic heart disease. Fei et al.38 reported
significant changes in HRV immediately prior to the occurrence of tachyarrhythmias in
patients with congestive heart failure. Fei et al.39 reported a significant increase in the
LF/HF ratio immediately before occurrence of idiopathic VT episodes. Also, Hayashi et
al.40 reported an increase in the LF/HF before the onset of ventricular tachycardia. Our
findings were in agreement with previous published literature. In our study, 49% of
patients were known to have cardiac conditions. Increased sympathetic activity (reflected
by increased LF power) was found to be arrhythmogenic. The LF power significantly
predicted the occurrence of both ventricular and supraventricular ectopic beats during
weaning. Although HF and VLF power did not change during weaning compared to
baseline, multiple regression analyses showed that HF power measured during weaning
was a significant predictor of occurrence of ventricular and supraventricular ectopic beats
during weaning; and VLF power measured during weaning was found to be a significant
predictor of the occurrence of ventricular ectopic beats but not of occurrence of
supraventricular beats during weaning.
All patients in this study demonstrated either ventricular or supraventricular
ectopic beats or both during weaning. The mean supraventricular ectopic beats per hour
during weaning were double the mean at baseline, while the mean of ventricular ectopic
beats per hour did not change. Frazier et al.17 reported that the number of supraventricular
ectopic beats per hour during weaning was almost double the number at baseline, and the
number of ventricular ectopic beats per hour decreased by nearly two thirds during
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weaning in 39 patients exposed to CPAP during weaning attempts. Thus, our results
mirrored the change in SVEs, but not VEs. This can be attributed to the degree of positive
ITP achieved during weaning and data measurements points of time. In our study, we
measured cardiac rhythm for 24- hours at baseline and for the first 2-hour after exposing
the patients to a combination of PS (8-15 cm H2O) and CPAP 5 cm H2O during weaning
trial. Frazier and associates measured cardiac rhythm for 24- hours at baseline; 1-hour
before, during, and up to 24 hours after exposing patients to a combination of PS10 cm
H2O and CPAP 10 cm H2O. The higher the positive ITP applied during weaning, the
greater is the impact on acute fluid shift into the intrathoracic vascular component, ANS
activity and in turn the greater is the negative effects on myocardial action potential. The
underlying disease process of enrolled patients may have an impact on occurrence of
ventricular and supraventricular ectopic beats. In our study, the heterogeneous patient
population was recruited from MICU, CCU, TICU, CTICU and NICU, while Frazier and
associates enrolled a homogeneous patient population from MICU only. Finally, patients
enrolled in both studies were critically ill. These patients were subjected to a wide variety
of procedures at baseline and during weaning that have varied impact on the occurrence
of cardiac dysrhythmias.
In this study, we hypothesized that cardiac dysrhythmias would contribute to
difficulty with weaning from MV and thus increase the length of time required for MV.
Multiple linear regression analyses revealed that the occurrence of supraventricular, but
not ventricular ectopic beats during weaning was a significant predictor of length of MV.
This study was the first to evaluate the impact of occurrence of cardiac dysrhythmias
during weaning on length of MV. These results advance our understanding of the
negative impact of cardiac dysrhythmias on cardiac contractility and myocardial oxygen
demand, and in turn weaning outcome. Therefore, cardiac rhythm should be
systematically evaluated during MV and weaning in order to decrease length of MV.
Study Limitations
There are some limitations to this study. First, the sample size is small and that
may affect the power of the study to detect differences. Larger sample sizes are
recommended for future studies. Second, we did not collect other biomarkers of
autonomic activity, such as plasma catecholamine levels and baroreflex sensitivity.
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However, power spectral analysis of HRV is a valid and reliable noninvasive indicator of
autonomic nervous system modulation activity. Third, in this study, a heterogeneous
patient population with various underlying diseases was included, which might have had
considerable effects on the length of MV. The reason of enrolling a heterogeneous patient
population was to mirror the actual patient population found in intensive care units, in
order to generalize the study findings to include patients with different underlying disease
processes. Fourth, the majority of patients were male (67%) and Caucasian (97%), which
may affect the generalizability of the study findings. Enrolling patients with approximate
numbers of both genders and different categories of ethnicity is recommended for future
studies. Fifth, according to the routine care followed in the proposed clinical area, the
process of weaning starts once the physician prescribes weaning. This resulted in the PI
missing the initial weaning trial for two patients. Sixth, the design of this study is a
repeated measures design. So, death or tracheostomy events that occurred before the first
weaning trial limited the number of patients with complete data for the two time periods.
Therefore, a larger sample size is recommended for future studies.
SUMMARY AND CONCLUSION
In summary, this study was the first to investigate the relationship of the
occurrence of cardiac dysrhythmias during weaning to the length of MV. We
demonstrated that changes in HRV measured during weaning significantly predicted the
occurrence of cardiac dysrhythmias during weaning and the occurrence of
supraventricular ectopic beats during weaning was a significant predictor of the length of
MV.

Early detection of ANS alterations and effective management of cardiac

dysrhythmias during weaning is of paramount importance because these alterations can
contribute to longer MV time.

Copyright© Muna Hassan Hammash 2010
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APPEDICES
Appendix A: Institutional Review Board
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Appendix B: Data collection instrument
Socio-demographic characteristics and clinical data collection instrument
ID#

Date of data collection

Date hospital admission

Unit

Date of ICU admission
Part 1: SOCIODEMOGRAPHIC CHARACTERISTICS
1. Sex: 0.______ Male

1.______ Female

2. Age ____ Years old_____
3. Marital Status:

0._____ Single
1._____ Married
2._____ Divorced/Separated
3._____ Widowed
4._____ Co-habitate (living with a good friend or partner)

4. Type of insurance: 1. Government insurance (Medicare, Medicaid, or military
medical)
2. Commercial insurance (fee-for service and PPO carriers)
3. HMO (health maintenance organization characterized by
coverage that provides healthcare services for members on a
prepaid basis).
4. None or self
5. Ethnicity:

1. _____ Black or African-American (not Hispanic or Latino)
2. _____ White or Caucasian (not Hispanic or Latino)
3. _____ Asian
4. _____ Hispanic or Latino
5. _____ American Indian or Alaskan Native
6. _____ Native Hawaiian or other Pacific Islander
7. _____ Other (please specify______________________________)

58

6. What is the highest level of education the patient have completed?
1. _______ Less than high school graduate
2. _______ High school graduate
3. _______ some post high school
4. _______ Some college
5. _______ Associate degree
6. _______ Bachelor’s degree
7. _______ Master’s degree
8. _______ Professional degree
9. _______ Doctoral degree
7. Patient’s Height _________________________, body weight _____________lbs
8. Hospital length of stay prior to ICU admission

days.

9. Hospital length of stay prior to ICU intubation

days.

10. Functional limitation prior to admission 0.______ No 1.______Yes.
If yes, describe
11. Regular medications prior to admission ______________________________
12. Does the patient have any previous history of mechanical ventilation?
0.______ No 1.______Yes
If yes, a- When?
b- Specify the cause
c- Length of previous mechanical ventilation _____________ days/hours
d- Complications during previous mechanical ventilation period
13. Does the patient have any history of cardiac rhythm disturbances?
0.______ No 1.______Yes
If yes, a- Specify
b- For how long?

days

c- What medication used for its management?
14. Medical diagnoses upon admission:
15. Reason for current mechanical ventilation:
1. Airway protection 2. Excessive work of breathing
3. Inadequate oxygenation

4. Hypercapnia

5. Other (please specify)
16. Length of current MV prior to beginning the study: _____________days/hours
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17. APACHE III score
Part 2-I: Clinical Data (Baseline)
Day #

ID#

Date

Physiological Status
GCS
Patient temperature
arterial pH
PaCO2
PaO2

WBC / RBC
Platelets
Hemoglobin
Hematocrit
Pulmonary Status
Ventilator mode

HCO3
SaO2
SpO2

E.T.T size/location
Set ventilator rate
Total rate

Glucose / Hgb A1C
BUN

Potassium

Spontaneous RR
Vt I( Set) / Vt
( returned)
Spontaneous Vt
exhaled
Pressure control set
above PEEP
Pressure support

Chloride
CO2
Calcium(tot)/Ionized
Bilirubin

PEEP level
CPAP level
FiO2
Minute Vent total

Albumin
Magnesium

Minute Vent expired
Minute Vent
inspired
Minute Vent esp

Creatinine
Sodium

Phosphorous

Date and description of 12 lead EKGs

Date and description of CXRs

Date and description of cardiac cath/echo
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Cdyne / Cst
Airway resistance
WOBv / WOBp
P O.1
Ti / Ttot (cycle time)
Peak airway / Mean
airway pressures
RSBI
PaO2/FiO2
Self extubation
incidence
Re-intubation
Cardiovascular
Status
Systolic BP
Diastolic BP
Mean arterial
pressure
HR
CVP
I&O Status
Total 24 hour intake
Total 24 hour output
Cumulative Intake
Cumulative Output
Cumulative fluid
balance

Current medications and dosages
Prescribed Drug
Name

Dose/Route/Frequency/Dates of
Administration

Comments (Total Dose
per 24 hours)

Part 3: Events summary and patients disposition

1. Total length of stay:

Hospital

ICU

2. Total # ventilator ________ days _____________ hours.
3. Number of weaning trials
4.

a. Initial weaning trial date and time _____________
b. Mode of weaning _____________
c. Length of weaning trial _____________
d. Weaning outcome: success

Failure

5. If failed weaning trial, reasons identified in the patient medical record
6. Tracheostomy:

Yes

No
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1.

2.
3.

4.

5.

6.
7.
8.

9.

10.

11.

12.

13.

REFERENCES
Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE, Benito S,
Epstein SK, Apezteguia C, Nightingale P, Arroliga AC, Tobin MJ. Characteristics
and outcomes in adult patients receiving mechanical ventilation: a 28-day
international study. Jama. 2002;287(3):345-355.
Tobin MJ. Advances in mechanical ventilation. The New England journal of
medicine. 2001;344(26):1986-1996.
Esteban A, Alia I, Ibanez J, Benito S, Tobin MJ. Modes of mechanical ventilation
and weaning. A national survey of Spanish hospitals. The Spanish Lung Failure
Collaborative Group. Chest. 1994;106(4):1188-1193.
Meade M, Guyatt G, Griffith L, Booker L, Randall J, Cook DJ. Introduction to a
series of systematic reviews of weaning from mechanical ventilation. Chest.
2001;120(6 Suppl):396S-399S.
Esteban A, Anzueto A, Alia I, Gordo F, Apezteguia C, Palizas F, Cide D,
Goldwaser R, Soto L, Bugedo G, Rodrigo C, Pimentel J, Raimondi G, Tobin MJ.
How is mechanical ventilation employed in the intensive care unit? An
international utilization review. American journal of respiratory and critical care
medicine. 2000;161(5):1450-1458.
Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated pneumonia and
mortality: A systematic review of observational studies. Crit Care Med. 2009.
Tobin MJ. Principles and practice of mechanical ventilation. 2nd ed. New York:
McGraw-Hill; 2006.
Esteban A, Alia I, Gordo F, Fernandez R, Solsona JF, Vallverdu I, Macias S,
Allegue JM, Blanco J, Carriedo D, Leon M, de la Cal MA, Taboada F, Gonzalez
de Velasco J, Palazon E, Carrizosa F, Tomas R, Suarez J, Goldwasser RS.
Extubation outcome after spontaneous breathing trials with T-tube or pressure
support ventilation. The Spanish Lung Failure Collaborative Group. American
journal of respiratory and critical care medicine. 1997;156(2 Pt 1):459-465.
Esteban A, Frutos F, Tobin MJ, Alia I, Solsona JF, Valverdu I, Fernandez R, de la
Cal MA, Benito S, Tomas R, et al. A comparison of four methods of weaning
patients from mechanical ventilation. Spanish Lung Failure Collaborative Group.
The New England journal of medicine. 1995;332(6):345-350.
Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelly PT, Johnson MM,
Browder RW, Bowton DL, Haponik EF. Effect on the duration of mechanical
ventilation of identifying patients capable of breathing spontaneously. The New
England journal of medicine. 1996;335(25):1864-1869.
Esteban A AI, Benito S, Tobin MJ, and the Spanish Lung Failure Collaborative
Group. Modes of mechanical ventilation and weaning. Chest. 1994;106:11881193.
Frazier SK, Stone KS, Schertel ER, Moser DK, Pratt JW. A comparison of
hemodynamic changes during the transition from mechanical ventilation to Tpiece, pressure support, and continuous positive airway pressure in canines. Biol
Res Nurs. 2000;1(4):253-264.
Zobel G, Dacar D, Rodl S. Hemodynamic effects of different modes of
mechanical ventilation in acute cardiac and pulmonary failure: an experimental
study. Critical care medicine. 1994;22(10):1624-1630.

62

14.
15.
16.

17.

18.

19.

20.

21.
22.
23.

24.

25.

26.

27.

Pinsky MR. Cardiovascular issues in respiratory care. Chest. 2005;128(5 Suppl
2):592S-597S.
Steingrub JS, Tidswell M, Higgins TL. Hemodynamic consequences of heart-lung
interactions. J Intensive Care Med. 2003;18(2):92-99.
Demling RH, Read T, Lind LJ, Flanagan HL. Incidence and morbidity of
extubation failure in surgical intensive care patients. Critical care medicine.
1988;16(6):573-577.
Frazier SK, Stone KS, Moser D, Schlanger R, Carle C, Pender L, Widener J,
Brom H. Hemodynamic changes during discontinuation of mechanical ventilation
in medical intensive care unit patients. Am J Crit Care. 2006;15(6):580-593; quiz
594.
MacIntyre NR, Cook DJ, Ely EW, Jr., Epstein SK, Fink JB, Heffner JE, Hess D,
Hubmayer RD, Scheinhorn DJ. Evidence-based guidelines for weaning and
discontinuing ventilatory support: a collective task force facilitated by the
American College of Chest Physicians; the American Association for Respiratory
Care; and the American College of Critical Care Medicine. Chest. 2001;120(6
Suppl):375S-395S.
Chatila W, Ani S, Guaglianone D, Jacob B, Amoateng-Adjepong Y, Manthous
CA. Cardiac ischemia during weaning from mechanical ventilation. Chest.
1996;109(6):1577-1583.
Frazier SK, Moser DK, Stone KS. Cardiac power output during transition from
mechanical to spontaneous ventilation in canines. J Cardiovasc Nurs.
2001;15(2):23-32.
Goldstone J. The pulmonary physician in critical care. 10: difficult weaning.
Thorax. 2002;57(11):986-991.
Hurford WE, Favorito F. Association of myocardial ischemia with failure to wean
from mechanical ventilation. Critical care medicine. 1995;23(9):1475-1480.
Hurtado FJ, Beron M, Olivera W, Garrido R, Silva J, Caragna E, Rivara D.
Gastric intramucosal pH and intraluminal PCO2 during weaning from mechanical
ventilation. Critical care medicine. 2001;29(1):70-76.
Nozawa E, Azeka E, Ignez ZM, Feltrim Z, Auler Junior JO. Factors associated
with failure of weaning from long-term mechanical ventilation after cardiac
surgery. Int Heart J. 2005;46(5):819-831.
Srivastava S, Chatila W, Amoateng-Adjepong Y, Kanagasegar S, Jacob B, Zarich
S, Manthous CA. Myocardial ischemia and weaning failure in patients with
coronary artery disease: an update. Critical care medicine. 1999;27(10):21092112.
Tobin MJ, Perez W, Guenther SM, Semmes BJ, Mador MJ, Allen SJ, Lodato RF,
Dantzker DR. The pattern of breathing during successful and unsuccessful trials
of weaning from mechanical ventilation. Am Rev Respir Dis. 1986;134(6):11111118.
Lemaire F, Teboul JL, Cinotti L, Giotto G, Abrouk F, Steg G, Macquin-Mavier I,
Zapol WM. Acute left ventricular dysfunction during unsuccessful weaning from
mechanical ventilation. Anesthesiology. 1988;69(2):171-179.

63

28.

29.
30.
31.

32.
33.

34.
35.
36.
37.

38.

39.

40.

41.

Frazier SK, Brom H, Widener J, Pender L, Stone KS, Moser D. Prevalence of
myocardial ischemia during mechanical ventilation and weaning and its effects on
weaning success. Heart Lung. 2006;35:363-373.
Pinsky MR. Cardiovascular effects of ventilatory support and withdrawal. Anesth
Analg. 1994;79(3):567-576.
Pinsky MR. Breathing as exercise: the cardiovascular response to weaning from
mechanical ventilation. Intensive care medicine. 2000;26(9):1164-1166.
Richard C, Teboul JL, Archambaud F, Hebert JL, Michaut P, Auzepy P. Left
ventricular function during weaning of patients with chronic obstructive
pulmonary disease. Intensive care medicine. 1994;20(3):181-186.
Robotham JL, Becker LC. The cardiovascular effects of weaning: stratifying
patient populations. Intensive care medicine. 1994;20(3):171-172.
Frazier SK, Moser DK, Stone KS. Heart rate variability and hemodynamic
alterations in canines with normal cardiac function during exposure to pressure
support, continuous positive airway pressure, and a combination of pressure
support and continuous positive airway pressure. Biol Res Nurs. 2001;2(3):167174.
Shen HN, Lin LY, Chen KY, Kuo PH, Yu CJ, Wu HD, Yang PC. Changes of
heart rate variability during ventilator weaning. Chest. 2003;123(4):1222-1228.
Chen PS, Tan AY. Autonomic nerve activity and atrial fibrillation. Heart Rhythm.
2007;4(3 Suppl):S61-64.
Coccagna G, Capucci A, Bauleo S, Boriani G, Santarelli A. Paroxysmal atrial
fibrillation in sleep. Sleep. 1997;20(6):396-398.
Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten
EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary
heart disease and mortality from several causes: the ARIC Study. Atherosclerosis
Risk In Communities. Circulation. 2000;102(11):1239-1244.
Fei L, Keeling PJ, Gill JS, Bashir Y, Statters DJ, Poloniecki J, McKenna WJ,
Camm AJ. Heart rate variability and its relation to ventricular arrhythmias in
congestive heart failure. Br Heart J. 1994;71(4):322-328.
Fei L, Statters DJ, Hnatkova K, Poloniecki J, Malik M, Camm AJ. Change of
autonomic influence on the heart immediately before the onset of spontaneous
idiopathic ventricular tachycardia. J Am Coll Cardiol. 1994;24(6):1515-1522.
Hayashi H, Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H. Role of
sympathovagal balance in the initiation of idiopathic ventricular tachycardia
originating from right ventricular outflow tract. Pacing Clin Electrophysiol.
1997;20(10 Pt 1):2371-2377.
Huikuri HV, Raatikainen MJP, Moerch-Joergensen R, Hartikainen J, Virtanen V,
Boland J, Anttonen O, Hoest N, Boersma LVA, Platou ES, Messier MD, BlochThomsen P-E, Arrhythmias ftC, Risk Stratification after Acute Myocardial
Infarction study group. Prediction of fatal or near-fatal cardiac arrhythmia events
in patients with depressed left ventricular function after an acute myocardial
infarction. Eur Heart J. 2009;30(6):689-698.

64

42.

43.

44.

45.
46.
47.
48.
49.
50.

51.
52.

53.

54.

55.

56.

57.

La Rovere MT, Bigger JT, Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex
sensitivity and heart-rate variability in prediction of total cardiac mortality after
myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After
Myocardial Infarction) Investigators. Lancet. 1998;351(9101):478-484.
La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R,
Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Shortterm heart rate variability strongly predicts sudden cardiac death in chronic heart
failure patients. Circulation. 2003;107(4):565-570.
Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in
cardiovascular disease: physiological basis and prognostic implications. J Am Coll
Cardiol. 2008;51(18):1725-1733.
Verrier RL, Antzelevitch C. Autonomic aspects of arrhythmogenesis: the
enduring and the new. Curr Opin Cardiol. 2004;19(1):2-11.
Franz MR. Mechano-electrical feedback in ventricular myocardium. Cardiovasc
Res. 1996;32(1):15-24.
Pinsky MR. The hemodynamic consequences of mechanical ventilation: an
evolving story. Intensive care medicine. 1997;23(5):493-503.
Pinsky MR. The effects of mechanical ventilation on the cardiovascular system.
Crit Care Clin. 1990;6(3):663-678.
Shekerdemian L, Bohn D. Cardiovascular effects of mechanical ventilation. Arch
Dis Child. 1999;80(5):475-480.
Pinsky MR. Effect of mechanical ventilation on heart-lung interactions. In: Tobin
MJ, ed. Principless and practice of mechanical ventilation. New York: McGrawHill; 2006.
Wise RA, Robotham JL, Summer WR. Effects of spontaneous ventilation on the
circulation. Lung. 1981;159(4):175-186.
Karam M, Wise RA, Natarajan TK, Permutt S, Wagner HN. Mechanism of
decreased left ventricular stroke volume during inspiration in man. Circulation.
1984;69(5):866-873.
Pinsky MR. Determinants of pulmonary arterial flow variation during respiration.
Journal of applied physiology: respiratory, environmental and exercise
physiology. 1984;56(5):1237-1245.
Karam M, Wise RA, Natarajan TK, Permutt S, Wagner HN. Mechanism of
decreased left ventricular stroke volume during inspiration in man. Vol 69;
1984:866-873.
Jardin F, Delorme G, Hardy A, Auvert B, Beauchet A, Bourdarias JP.
Reevaluation of hemodynamic consequences of positive pressure ventilation:
emphasis on cyclic right ventricular afterloading by mechanical lung inflation.
Anesthesiology. 1990;72(6):966-970.
Koganov Y, Weiss YG, Oppenheim A, Elami A, Pizov R. Positive end-expiratory
pressure increases pulmonary venous vascular resistance in patients after coronary
artery surgery. Critical care medicine. 1997;25(5):767-772.
Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure
ventilation in clinical practice: from hemodynamic subsets to respirator settings.
Intensive care medicine. 2003;29(9):1426-1434.

65

58.

59.

60.

61.

62.
63.

64.

65.

66.
67.
68.
69.
70.

71.
72.
73.
74.

Beaussier M, Coriat P, Perel A, Lebret F, Kalfon P, Chemla D, Lienhart A, Viars
P. Determinants of systolic pressure variation in patients ventilated after vascular
surgery. Journal of cardiothoracic and vascular anesthesia. 1995;9(5):547-551.
Fessler HE, Brower RG, Wise RA, Permutt S. Mechanism of reduced LV
afterload by systolic and diastolic positive pleural pressure. Vol 65; 1988:12441250.
Ramamoorthy C, Rooney MW, Dries DJ, Mathru M. Aggressive hydration during
continuous positive-pressure ventilation restores atrial transmural pressure,
plasma atrial natriuretic peptide concentrations, and renal function. Crit Care Med.
1992;20(7):1014-1019.
Grap MJ, Strickland D, Tormey L, Keane K, Lubin S, Emerson J, Winfield S,
Dalby P, Townes R, Sessler CN. Collaborative practice: development,
implementation, and evaluation of a weaning protocol for patients receiving
mechanical ventilation. Am J Crit Care. 2003;12(5):454-460.
Mancebo J. Weaning from mechanical ventilation. Eur Respir J. 1996;9(9):19231931.
Matic I, Majeric-Kogler V. Comparison of pressure support and T-tube weaning
from mechanical ventilation: randomized prospective study. Croat Med J.
2004;45(2):162-166.
Tsai BM, Wang M, Turrentine MW, Mahomed Y, Brown JW, Meldrum DR.
Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms
to potential therapies. The Annals of thoracic surgery. 2004;78(1):360-368.
Hansen D, Craig,S., Hondeghem,L. Stretch-induced arrhythmias in the isolated
canine ventricles : evidence for the importance of mechanoelectrical feedback.
Circulation. 1990;81:1094-1105.
Kohl P, Sachs F. Mechanoelectric feedback in cardiac cells. 2001;359:1173-1185.
Franz M, Bode, F. Mechano-electrical feedback underlying arrhythmias:The atrial
fibrillation case. Progress in Biophysics& Molecular Biology. 2003;82:163-174.
Franz MR. Mechano-electrical feedback in ventricular myocardium.
Cardiovasculr Research. 1996;32:15-24.
Lab MJ. Mechanoelectric feedback (transduction) in heart: Concepts and
implications Cardiovasculr Research. 1996;32:3-14.
Lerman B, Burkhoff,D., Yue,D., Sagawa,K. Mechanoelectrical feedback:
independent role of preload and contractility in modulation of canine ventricular
excitability. J. Clin.Invest. 1985;76:1843-1850.
Lerman BB, Engelstein ED, Burkhoff D. Mechanoelectrical Feedback: Role of
2001.
Nazir SA, Lab,M.J. Mechanoelectrical feedback in the atrium of the isolated
guinea -pig heart Cardiovasculr Research. 1996;32:112-119.
Taggart P. Mechano- electrical feedback in human heart. Cardiovasculr Research.
1996;32:38-43.
Hurford WE, Lynch KE, Strauss HW, Lowenstein E, Zapol WM. Myocardial
perfusion as assessed by thallium-201 scintigraphy during the discontinuation of
mechanical ventilation in ventilator-dependent patients. Anesthesiology.
1991;74(6):1007-1016.

66

75.

76.

77.

78.
79.
80.
81.
82.
83.

84.

85.
86.

87.

88.
89.

90.

91.

Jubran A, Mathru M, Dries D, Tobin MJ. Continuous recordings of mixed venous
oxygen saturation during weaning from mechanical ventilation and the
ramifications thereof. American journal of respiratory and critical care medicine.
1998;158(6):1763-1769.
Walley KR, Becker CJ, Hogan RA, Teplinsky K, Wood LD. Progressive
hypoxemia limits left ventricular oxygen consumption and contractility.
Circulation research. 1988;63(5):849-859.
Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald's heart disease: a
textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders;
2005.
Levy MN, Pappano AJ. Cardiovascular Physiology. 9th ed. Philadelphia: Mosby;
2007.
Opie LH. Heart physiology: from cell to circulation. 4 th ed. Philadelphia:
Lippincott; 2004.
Levick JR. An Introduction to Cardiovascular Physiology. London: Arnold; 2003.
Woods SL, Froelicher ES, Motzer S, Bridges EJ. Cardiac Nursing. Philadelphia:
Lippincott; 2005.
Woods SL, Froelicher E, Motzer S, Bridges E. Cardiac Nursing. 5th ed.
Philadelphia: Lippincott Williams & Wilkins; 2005.
Zipes P, Libby P, Bonow R, Braunwald E. Braunwald's Heart Disease: A
Textbook of Cardiovascular Medicine. seven ed. Philadelphia: Elsevier Saunders;
2005.
Rice J, Winslow R, Dekanski J, McVeigh E. Model studies of the role of
mechano-sensitive currents in the generation of cardiac arrhythmias. J Theor Biol.
1998;190:295-312.
Dean JW, Lab MJ. Arrhythmia in heart failure: role of mechanically induced
changes in electrophysiology. Lancet. 1989;1(8650):1309-1312.
Hansen DE, Craig CS, Hondeghem LM. Stretch-induced arrhythmias in the
isolated canine ventricle. Evidence for the importance of mechanoelectrical
feedback. Circulation. 1990;81(3):1094-1105.
Lerman BB, Burkhoff D, Yue DT, Franz MR, Sagawa K. Mechanoelectrical
feedback: independent role of preload and contractility in modulation of canine
ventricular excitability. J Clin Invest. 1985;76(5):1843-1850.
Nazir SA, Lab MJ. Mechanoelectric feedback in the atrium of the isolated guineapig heart. Cardiovasc Res. 1996;32(1):112-119.
Stacy GP, Jr., Jobe RL, Taylor LK, Hansen DE. Stretch-induced depolarizations
as a trigger of arrhythmias in isolated canine left ventricles. Am J Physiol.
1992;263(2 Pt 2):H613-621.
Dargie HJ, Cleland JG, Leckie BJ, Inglis CG, East BW, Ford I. Relation of
arrhythmias and electrolyte abnormalities to survival in patients with severe
chronic heart failure. Circulation. 1987;75(5 Pt 2):IV98-107.
Podrid PJ. Potassium and ventricular arrhythmias. The American journal of
cardiology. 1990;65(10):33E-44E; discussion 52E.

67

92.

93.
94.

95.

96.

97.

98.

99.
100.

101.

102.

103.

104.

105.

Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S,
Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ. Depressed
heart rate variability as an independent predictor of death in chronic congestive
heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J
Cardiol. 1997;79(12):1645-1650.
Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation
explored in the frequency domain. Circulation. 1991;84(2):482-492.
Bilchick KC, Fetics B, Djoukeng R, Fisher SG, Fletcher RD, Singh SN, Nevo E,
Berger RD. Prognostic value of heart rate variability in chronic congestive heart
failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive
Heart Failure). Am J Cardiol. 2002;90(1):24-28.
Tapanainen JM, Thomsen PE, Kober L, Torp-Pedersen C, Makikallio TH, Still
AM, Lindgren KS, Huikuri HV. Fractal analysis of heart rate variability and
mortality after an acute myocardial infarction. Am J Cardiol. 2002;90(4):347-352.
Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several shortterm measures of RR variability to predict mortality after myocardial infarction.
Circulation. 1993;88(3):927-934.
Tsuji H, Larson MG, Venditti FJ, Jr., Manders ES, Evans JC, Feldman CL, Levy
D. Impact of reduced heart rate variability on risk for cardiac events. The
Framingham Heart Study. Circulation. 1996;94(11):2850-2855.
Galinier M, Pathak A, Fourcade J, Androdias C, Curnier D, Varnous S, Boveda S,
Massabuau P, Fauvel M, Senard JM, Bounhoure JP. Depressed low frequency
power of heart rate variability as an independent predictor of sudden death in
chronic heart failure. Eur Heart J. 2000;21(6):475-482.
Bernardi L, Porta C, Gabutti A, Spicuzza L, Sleight P. Modulatory effects of
respiration. Auton Neurosci. 2001;90(1-2):47-56.
Frazier SK, Moser DK, Schlanger R, Widener J, Pender L, Stone KS. Autonomic
tone in medical intensive care patients receiving mechanical ventilation and
during a CPAP weaning trial. Biol Res Nurs. 2008;9(4):301-310.
Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, Karam
R, Sonnenblick EH, Brum JM. Mortality in patients after a recent myocardial
infarction: a randomized, placebo-controlled trial of azimilide using heart rate
variability for risk stratification. Circulation. 2004;109(8):990-996.
Dimmer C, Tavernier R, Gjorgov N, Van Nooten G, Clement DL, Jordaens L.
Variations of autonomic tone preceding onset of atrial fibrillation after coronary
artery bypass grafting. Am J Cardiol. 1998;82(1):22-25.
Huikuri HV, Valkama JO, Airaksinen KE, Seppanen T, Kessler KM, Takkunen
JT, Myerburg RJ. Frequency domain measures of heart rate variability before the
onset of nonsustained and sustained ventricular tachycardia in patients with
coronary artery disease. Circulation. 1993;87(4):1220-1228.
Wen ZC, Chen SA, Tai CT, Huang JL, Chang MS. Role of autonomic tone in
facilitating spontaneous onset of typical atrial flutter. J Am Coll Cardiol.
1998;31(3):602-607.
Thuraisingham RA. Preprocessing RR interval time series for heart rate
variability analysis and estimates of standard deviation of RR intervals. Comput
Methods Programs Biomed. 2006;83(1):78-82.

68

106.

107.

108.

109.

110.

111.

112.

113.

114.
115.

116.

117.

118.

Heart rate variability: standards of measurement, physiological interpretation and
clinical use. Task Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology. Circulation.
1996;93(5):1043-1065.
Zollei E, Csillik A, Rabi S, Gingl Z, Rudas L. Respiratory effects on the
reproducibility of cardiovascular autonomic parameters. Clin Physiol Funct
Imaging. 2007;27(4):205-210.
Randall DC, Brown DR, Raisch RM, Yingling JD, Randall WC. SA nodal
parasympathectomy delineates autonomic control of heart rate power spectrum.
Am J Physiol. 1991;260(3 Pt 2):H985-988.
Brown TE, Beightol LA, Koh J, Eckberg DL. Important influence of respiration
on human R-R interval power spectra is largely ignored. J Appl Physiol.
1993;75(5):2310-2317.
Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function
analysis of the circulation: unique insights into cardiovascular regulation. Am J
Physiol. 1991;261(4 Pt 2):H1231-1245.
Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G,
Malfatto G, Dell'Orto S, Piccaluga E, et al. Power spectral analysis of heart rate
and arterial pressure variabilities as a marker of sympatho-vagal interaction in
man and conscious dog. Circ Res. 1986;59(2):178-193.
Malliani A, Pagani M, Lombardi F. Physiology and clinical implications of
variability of cardiovascular parameters with focus on heart rate and blood
pressure. Am J Cardiol. 1994;73(10):3C-9C.
Epstein S. Complications in ventilator supported patients. In: Tobin M, ed.
Principles and practice of mechanical ventilation. 2nd ed. New York: McGraw
Hill; 2006:877-902.
Epstein SK, Ciubotaru RL, Wong JB. Effect of failed extubation on the outcome
of mechanical ventilation. Chest. 1997;112(1):186-192.
Esteban A, Alia I, Tobin MJ, Gil A, Gordo F, Vallverdu I, Blanch L, Bonet A,
Vazquez A, de Pablo R, Torres A, de La Cal MA, Macias S. Effect of
spontaneous breathing trial duration on outcome of attempts to discontinue
mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir
Crit Care Med. 1999;159(2):512-518.
Tobin M. Role and interpretation of weaning predictors. As presented at the 5th
International Consensus Conference in Intensive Care Medicine: Weaning from
Mechanical Ventilation. . Hosted by ERS, ATS, ESICM, SCCM and SRLF;
Budapest; April 28-29, 2005.
Kollef MH, Shapiro SD, Silver P, St John RE, Prentice D, Sauer S, Ahrens TS,
Shannon W, Baker-Clinkscale D. A randomized, controlled trial of protocoldirected versus physician-directed weaning from mechanical ventilation. Crit
Care Med. 1997;25(4):567-574.
Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily
interruption of sedative infusions and complications of critical illness in
mechanically ventilated patients. Crit Care Med. 2004;32(6):1272-1276.

69

119.

120.

121.

122.

123.

124.
125.

126.

127.
128.

129.

130.

131.
132.

133.

Krishnan JA, Moore D, Robeson C, Rand CS, Fessler HE. A prospective,
controlled trial of a protocol-based strategy to discontinue mechanical ventilation.
Am J Respir Crit Care Med. 2004;169(6):673-678.
Dries DJ, McGonigal MD, Malian MS, Bor BJ, Sullivan C. Protocol-driven
ventilator weaning reduces use of mechanical ventilation, rate of early
reintubation, and ventilator-associated pneumonia. J Trauma. 2004;56(5):943951; discussion 951-942.
Perren A, Domenighetti G, Mauri S, Genini F, Vizzardi N. Protocol-directed
weaning from mechanical ventilation: clinical outcome in patients randomized for
a 30-min or 120-min trial with pressure support ventilation. Intensive Care Med.
2002;28(8):1058-1063.
Khamiees M, Raju P, DeGirolamo A, Amoateng-Adjepong Y, Manthous CA.
Predictors of extubation outcome in patients who have successfully completed a
spontaneous breathing trial. Chest. 2001;120(4):1262-1270.
Robriquet L, Georges H, Leroy O, Devos P, D'Escrivan T, Guery B. Predictors of
extubation failure in patients with chronic obstructive pulmonary disease. J Crit
Care. 2006;21(2):185-190.
Epstein SK. Decision to extubate. Intensive Care Med. 2002;28(5):535-546.
Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gasparetto A,
Lemaire F. Comparison of three methods of gradual withdrawal from ventilatory
support during weaning from mechanical ventilation. Am J Respir Crit Care Med.
1994;150(4):896-903.
Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, Belloni G,
Vilianis G, Fiore G, Cavallo F, Ranieri VM. Continuous positive airway pressure
for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA.
2005;293(5):589-595.
MacIntyre N. Discontinuing mechanical ventilatory support. Chest.
2007;132(3):1049-1056.
Mohsenifar Z, Hay A, Hay J, Lewis MI, Koerner SK. Gastric intramural pH as a
predictor of success or failure in weaning patients from mechanical ventilation.
Ann Intern Med. 1993;119(8):794-798.
Meade M, Guyatt G, Cook D, Griffith L, Sinuff T, Kergl C, Mancebo J, Esteban
A, Epstein S. Predicting success in weaning from mechanical ventilation. Chest.
2001;120(6 Suppl):400S-424S.
Frutos-Vivar F, Ferguson ND, Esteban A, Epstein SK, Arabi Y, Apezteguia C,
Gonzalez M, Hill NS, Nava S, D'Empaire G, Anzueto A. Risk factors for
extubation failure in patients following a successful spontaneous breathing trial.
Chest. 2006;130(6):1664-1671.
Afessa B, Hogans L, Murphy R. Predicting 3-day and 7-day outcomes of weaning
from mechanical ventilation. Chest. 1999;116(2):456-461.
Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of
trials of weaning from mechanical ventilation. N Engl J Med. 1991;324(21):14451450.
Lee KH, Hui KP, Chan TB, Tan WC, Lim TK. Rapid shallow breathing
(frequency-tidal volume ratio) did not predict extubation outcome. Chest.
1994;105(2):540-543.

70

134.
135.

136.

137.

138.

139.

140.

141.

142.

143.

Epstein SK. Etiology of extubation failure and the predictive value of the rapid
shallow breathing index. Am J Respir Crit Care Med. 1995;152(2):545-549.
Ihnsook J, Myunghee K, Jungsoon K. Predictive accuracy of severity scoring
system: a prospective cohort study using APACHE III in a Korean intensive care
unit. Int J Nurs Stud. 2003;40(3):219-226.
Keegan MT, Harrison BA, Brown DR, Whalen FX, Cassivi SD, Afessa B. The
acute physiology and chronic health evaluation III outcome prediction in patients
admitted to the intensive care unit after pneumonectomy. J Cardiothorac Vasc
Anesth. 2007;21(6):832-837.
Keegan MT, Whalen FX, Brown DR, Roy TK, Afessa B. Acute Physiology and
Chronic Health Evaluation (APACHE) III outcome prediction after major
vascular surgery. J Cardiothorac Vasc Anesth. 2008;22(5):713-718.
Lin CY, Tsai FC, Tian YC, Jenq CC, Chen YC, Fang JT, Yang CW. Evaluation
of outcome scoring systems for patients on extracorporeal membrane oxygenation.
Ann Thorac Surg. 2007;84(4):1256-1262.
Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman
H, Stanchina M, Vieillard-Baron A, Welte T. Weaning from mechanical
ventilation. Eur Respir J. 2007;29(5):1033-1056.
MacIntyre NR, Epstein SK, Carson S, Scheinhorn D, Christopher K, Muldoon S.
Management of patients requiring prolonged mechanical ventilation: report of a
NAMDRC consensus conference. Chest. 2005;128(6):3937-3954.
La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R,
Bigger JT, Jr., Camm AJ, Schwartz PJ. Baroreflex sensitivity and heart rate
variability in the identification of patients at risk for life-threatening arrhythmias:
implications for clinical trials. Circulation. 2001;103(16):2072-2077.
Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane
PW, Sommargren C, Swiryn S, Van Hare GF. Practice standards for
electrocardiographic monitoring in hospital settings: an American Heart
Association scientific statement from the Councils on Cardiovascular Nursing,
Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the
International Society of Computerized Electrocardiology and the American
Association of Critical-Care Nurses. Circulation. 2004;110(17):2721-2746.
Miwa C, Sugiyama Y, Mano T, Matsukawa T, Iwase S, Watanabe T, Kobayashi F.
Effects of aging on cardiovascular responses to gravity-related fluid shift in
humans. J Gerontol A Biol Sci Med Sci. 2000;55(6):M329-335.

71

VITA
December 8, 1976……………………………………………….Born in Kuwait, Kuwait
1998……………………………………………………………...B.S.N., University of
Jordan, College of
Nursing, Amman, Jordan
1998-1999……………………………………………………… Staff nurse, Surgical ICU
and Cardiothoracic ICU,
University of Jordan
Hospital,
Amman,
Jordan
2000-2002……………………………………………………… M.S.N., University of
Jordan, College of
Nursing, Amman, Jordan
2000-2002……………………………………………………… Staff nurse, Surgical ICU,
CCU, and
Cardiothoracic ICU,
Jordan Hospital,
Amman, Jordan
2002-2004……………………………………………………… Teaching and Research
Assistant, The
Hashemite University,
Zarqa, Jordan
2004-2010……………………………………………………… Research Assistant,
University of Kentucky,
Lexington, Kentucky
Publications
Lennie, T. A., Worrall-Carter, L., Hammash, M., Odom-Forren, J., Roser, L. P., Smith, C.
S., Trupp, R., Chung, M. L., & Moser, D. K. (2008). Relationship of heart failure
patients’ knowledge, perceived barriers and attitudes regarding low sodium diet
recommendations to adherence. Progress in Cardiovascular Nursing, 23, 6-11.
Hammash, M.H., Moser, D.K., Lennie, T.A., Chung, M.L., & Heo S. (2007)
Psychometrics of the Patient Health Questionnaire for the measurement of depressive
symptoms in patients with heart failure. Progress in Cardiovascular Nursing, 22 (2): 113
Honors and Awards
American Association of Critical Care Nurse- Philips Medical Research Award, 2009
Southern Nursing Research Society Dissertation Award, 2008
Muna Hassan Hammash

72

